Skip to main content
NCBI home page
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
[画像:Wiley Open Access Collection logo]
. 2025 Oct 29;16(6):e70032. doi: 10.1002/wrna.70032

Mixed Messages: Dynamic and Compositional Heterogeneity of Nuclear Messenger Ribonucleoprotein (mRNP) Complexes

Theresa Wechsler 1,2, Ryuta Asada 1, Ben Montpetit 1,2,
1 Department of Viticulture and Enology, University of California, Davis, California, USA
2 Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Group, University of California, Davis, California, USA
*

Correspondence: Ben Montpetit (benmontpetit@ucdavis.edu)

Corresponding author.

Revised 2025 Sep 28; Received 2025 Aug 25; Accepted 2025 Oct 15; Issue date 2025 Nov-Dec.

© 2025 The Author(s). WIREs RNA published by Wiley Periodicals LLC.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMCID: PMC12569565 PMID: 41158057

ABSTRACT

Messenger ribonucleoprotein (mRNP) complexes assemble co‐transcriptionally in the nucleus as RNA‐binding proteins (RBPs) engage nascent transcripts. Ongoing RNA processing and RBP dynamics generate a diverse set of mRNPs, often producing a mature mRNA—capped, spliced, and polyadenylated—within a compact mRNP particle poised for nuclear export. The processing, packaging, and export of nuclear mRNPs are tightly regulated to ensure the fidelity of gene expression and to reprogram cellular function under changing organismal and environmental conditions. Understanding the compositional and organizational dynamics of nuclear mRNP assembly and maturation is essential, as dysregulation is linked to viral infections and a range of human diseases, including neurological disorders and cancer. Recent structural, biochemical, and in‐cell studies have revealed key roles for the evolutionarily conserved Yra1/ALYREF proteins and the TRanscription‐EXport (TREX) complex in mRNP packaging and export, highlighting broadly conserved functions across eukaryotes. While many questions remain, these advances have deepened our understanding of nuclear mRNA metabolism and offer new opportunities to investigate how disruptions in mRNA biogenesis and export factors, and their associated processes, contribute to disease.

This article is categorized under:

  • RNA Interactions with Proteins and Other Molecules > RNA‐Protein Complexes

  • RNA Interactions with Proteins and Other Molecules > Protein‐RNA Interactions: Functional Implications

  • RNA Export and Localization > Nuclear Export/Import

Keywords: ALYREF, gene expression, mRNA, mRNP, RBP, RNA‐binding protein, Saccharomyces cerevisiae , THO, TREX, Yra1


RNA‐protein (RNP) complexes formed by a network of RNA–RNA, RNA–protein, and protein–protein interactions are central to gene expression. mRNP compositional heterogeneity underlies precise regulation (e.g., export, storage, translation, and decay), enabling cells to adapt to changing conditions, with changes in composition further linked to stress responses, infection, neurological disease, and cancer.

[画像:graphic file with name WRNA-16-e70032-g001.jpg]

1. Introduction

Eukaryotic gene expression involves a series of spatially regulated processes, starting in the nucleus and continuing in the cytoplasm. These dynamic mRNA‐centric events are orchestrated by RNA‐binding proteins (RBPs) in the form of messenger ribonucleoprotein (mRNP) complexes (Khong and Parker 2020; Singh et al. 2015). RBPs are recruited to the transcription site to process and package the emerging transcript as RNA polymerase II (RNAPII) synthesizes the nascent mRNA (Figure 1). Continued mRNP processing and packaging after release from the transcription site ultimately facilitate nuclear export, with many mRNP components serving as adaptor proteins to engage the mRNA export receptor heterodimer (Mex67‐Mtr2 in yeast/NXF1‐NXT1 in mammals) and facilitate mRNP passage through a nuclear pore complex into the cytoplasm (Ashkenazy‐Titelman et al. 2020). The identity of many of the protein constituents of nuclear mRNPs has been cataloged via purification and mass spectrometry (Oeffinger et al. 2007; Singh et al. 2012). mRNP packaging is also a central component of quality control, with impaired mRNP formation causing retention of mRNPs at the transcription site or within the nucleoplasm, ultimately leading to the mRNA being targeted by nuclear degradation machinery (Jensen et al. 2003; Soheilypour and Mofrad 2018). Once in the cytoplasm, mRNPs continue to change via exchange with cytoplasmic RBPs to direct translation, localization, and mRNA decay.

FIGURE 1.

[画像:FIGURE 1]

Composition and dynamics of nuclear mRNPs. Nuclear mRNPs are assembled co‐transcriptionally from a diverse set of protein components, including key components listed in the bottom left panel (also see Box 1). Throughout transcription, and following release from the transcription site, the composition of individual mRNPs will vary across the stages of mRNA processing and mRNP maturation, concluding with mRNA export or decay via nuclear surveillance. In mammalian cells, this includes trafficking of some mRNPs through nuclear speckles, where additional processing including post‐transcriptional splicing is thought to occur. When nuclear mRNPs reach a nuclear pore complex, they may dock via interactions with TREX‐2 and/or other nucleoporins, which may involve nuclear pores of distinct functions (e.g., basket vs. basket‐less NPCs). Here, remodeling can take place to remove nuclear RBPs and promote directional mRNP export (e.g., removal of the TREX component Sub2/UAP56 via TREX‐2 binding). Export receptors, Mex67‐Mtr2/NXF1‐NXT1, can also be loaded at this stage, facilitating the transport of mRNA through the NPC.

It is known that RBPs direct many facets of gene expression by binding, organizing, and promoting interactions of the mRNP with other cellular machinery. This is exemplified by the compact organization of nuclear mRNPs vs. elongated and/or closed‐loop forms of cytoplasmic mRNPs (Adivarahan et al. 2018; Ashkenazy‐Titelman et al. 2022; Björk and Wieslander 2017; Khong and Parker 2018; Rissland 2017), which are linked to nuclear export and translation regulation, respectively. As such, understanding varied RBP compositions and resulting mRNP architectures is central to understanding gene expression regulation, yet the configurations of individual mRNPs across gene expression are not well understood. Furthermore, disease‐linked mutations are widespread in RBP genes, indicating the importance of understanding the connection between individual RBP function(s) and gene expression regulation (De Conti et al. 2017; Gebauer et al. 2021).

Decades of biochemistry, cell and molecular biology, and genetics have identified RBPs and detailed many individual activities across gene expression. Additionally, advancements of high‐throughput techniques to capture mRNA–protein interactomes have identified RNA‐associated proteomes in bacteria (Queiroz et al. 2019; Stenum et al. 2023), yeast (Beckmann et al. 2015; Mitchell et al. 2013), human (Baltz et al. 2012; Castello et al. 2012; Perez‐Perri et al. 2018), mouse (Kwon et al. 2013), fly (Sysoev et al. 2016), plants (Reichel et al. 2016), as well as viruses (S. Lee et al. 2021), identifying hundreds to thousands of RBPs in each case (Hentze et al. 2018). Identified RNA‐associated proteins include many with canonical RNA binding domains, as well as numerous proteins previously uncharacterized as RBPs. For example, the human mRNA interactome is significantly enriched for proteins with intrinsically disordered regions (IDRs), with uncharacterized RBPs often containing IDRs (Castello et al. 2012), suggesting an important link with RNA biology. Recent interactome screening of ~100 RBPs further revealed protein–protein interactions and RNA‐dependent interactions among RBPs whose reported functions are distinct in mRNA metabolism (e.g., interaction between a splicing factor and cytoplasmic stress granule components), suggesting multi‐functional roles for RBPs across gene expression (Fradera‐Sola et al. 2023; Street et al. 2024). In addition, an analysis of the binding sites of 356 RBPs by eCLIP, a high‐resolution transcriptome‐wide RBP binding sites mapping technique, in human cells revealed the existence of non‐uniform binding across transcripts from the same gene (Van Nostrand et al. 2020).

Altogether, emerging data indicate that mRNP composition is complex, dynamic, and heterogeneous between mRNPs from different genes and within mRNPs produced from the same gene. Furthermore, the widely different characteristics of each mRNA (e.g., length, GC content, secondary structure, etc.) are expected to contribute to mRNP heterogeneity through varied engagement with RBPs. This ultimately raises questions surrounding mechanisms governing mRNP heterogeneity and their importance to gene expression. In this review, we summarize recent advancements in the understanding of nuclear mRNP composition, organization, and dynamics in S. cerevisiae, as well as mammalian systems, which is further revealing how mRNPs vary and how these differences are associated with gene expression.

2. Nuclear mRNP Composition

Given the core processing events of gene expression for each transcript, a common set of factors is expected to associate with each nuclear mRNP (Detailed in Box 1 and summarized in Figure 1); however, it is not expected that a given RBP is always present or will exist in a fixed stoichiometry with other RBPs in an mRNP. While some datasets have investigated compositional heterogeneity across mRNPs, such as varied association of RBPs based on transcript classes (Baejen et al. 2014; Tuck and Tollervey 2013), compositional differences are often invisible within proteomics and RNA‐binding site datasets that represent an ensemble average of the total population of nuclear and cytoplasmic mRNPs across many cells. To this end, single‐molecule imaging is a powerful tool that allows the visualization of individual components within single complexes (Ha et al. 2022), which our group recently applied to the understanding of nuclear mRNP composition in Saccharomyces cerevisiae (Asada et al. 2023). Using an imaging approach termed mRNP‐SiMPull, the frequency, stoichiometry, and co‐occupancy of 15 nuclear mRNP components were analyzed, revealing that yeast nuclear mRNPs are comprised of a combination of core factors (RBPs that are commonly associated with the global mRNP population) and variable factors (RBPs only present in a subset of the mRNP population).

BOX 1. mRNP Nuclear Processing and Export Factors.

Cap binding proteins.

Nascent transcription by RNAPII leads to the recruitment of the 5′ capping enzyme and formation of the m7G cap structure on mRNA (Ramanathan et al. 2016). This modification results in the recruitment of the nuclear cap‐binding complex (CBC), which is composed of Cbp80 and Cbp20 in yeast and NCBP1 and NCBP2 in humans (Rambout and Maquat 2020). Of these, Cbp20/NCBP2 directly binds to the 5′ cap, while Cbp80/NCBP1 supports the interaction. CBC has a crucial role in the subsequent mRNA biogenesis steps, including transcription elongation, splicing, and 3′ end processing, by mediating interactions with various regulatory factors involved in these processes (Rambout and Maquat 2020). CBC association also facilitates the recruitment of RBPs linked to the nuclear mRNA export, underscoring its important role in mRNP packaging (Cheng et al. 2006; Clarke et al. 2024; Sen et al. 2019; Viphakone et al. 2019; Wechsler et al. 2025). The binding of CBC on the 5′ cap is also crucial to the fidelity and quality control of capping, with an interaction between Cbp80 and a core nuclear RBP component, Npl3, which, in the case of improper capping, triggers transcript degradation (Klama et al. 2022).

In addition to CBC, the cytoplasmic cap binding protein eIF4E is involved in nuclear mRNA processing and export (Mars et al. 2024). eIF4E is known to shuttle between the nucleus and cytoplasm, with significant amounts detected in the nuclei of various species, including yeast (Lang et al. 1994) and human (Cohen et al. 2001; Iborra et al. 2001). In mammals, eIF4E is imported into the nucleus by importin 8 (Volpon et al. 2016) and is involved in gene selective mRNA export. Specifically, eIF4E recognizes the 5' cap of nuclear mRNAs which have an eIF4E sensitivity element (4E‐SE), composed of a specific RNA stem‐loop pair, typically contained at the 3'UTR (Culjkovic et al. 2005). 4E‐SE is recognized by LRPPRC, and the interaction with eIF4E stabilizes these RBPs on target mRNPs (Topisirovic et al. 2009; Volpon et al. 2017). Unlike the conventional mRNA export pathway, eIF4E‐dependent export is mediated by CRM1, an export receptor commonly associated with the nuclear export of proteins, snRNAs, and rRNAs, through its interaction with LRPPRC (Culjkovic et al. 2006; Volpon et al. 2017).

Serine/Arginine‐rich (SR) proteins.

Human SR proteins are a class of RBPs with roles in nuclear mRNA processing, most notably an essential role in splicing, with some shuttling SR proteins also implicated in regulating nuclear export and translation in the cytoplasm (Howard and Sanford 2015; Jeong 2017; Wegener and Müller‐McNicoll 2019). These proteins are characterized by the presence of an RS domain enriched for serine and arginine residues and one or two RNA recognition motifs (RRMs). In S. cerevisiae , there are three "SR‐like" proteins (Npl3, Hrb1, Gbp2) with similarly documented nuclear roles in splicing and quality control of mRNA processing.

The yeast SR‐like protein, Npl3, is one of the most abundant nuclear RBPs with roles in mRNA biogenesis and export. Npl3 is recruited to the transcription site through the interaction with phosphorylated RNAPII C‐terminal domain (CTD) (Dermody et al. 2008; Gupta et al. 2023). Mutations disrupting Npl3 RNA binding impair recruitment and stability of the other nuclear mRNP components, highlighting the crucial role of Npl3 in mRNP assembly and organization (Keil et al. 2023). Similar to mammalian SR‐proteins, Npl3 is also involved in splicing (Kress et al. 2008; Sandhu et al. 2021), with a role in multiple steps of spliceosome function (e.g., U1 snRNP dissociation mediated by DEAD‐box helicase Prp28 (Yeh et al. 2021) and U2/U6 snRNAs duplex formation of Bact complex (Moursy et al. 2023)). The other SR‐like proteins encoded in yeast, Gbp2 and Hrb1, are involved in quality control to ensure the export of properly spliced mRNAs (Hackmann et al. 2014). These SR‐like proteins are recruited to the mRNA during the late step of the splicing and sort the mRNA for export or degradation depending on the status of intron removal. All three of these SR‐like proteins act as adaptor proteins for the mRNA export receptor Mex67‐Mtr2 to facilitate export (Gilbert and Guthrie 2004; Hackmann et al. 2014).

In mammals, a total of 12 SR proteins are encoded, referred to as serine/arginine‐rich splicing factors (SRSF) 1 to 12 (Wegener and Müller‐McNicoll 2019). CLIP‐seq analysis to identify SRSFs' target mRNAs and their binding sites revealed that SRSFs occupy most of the exons of protein‐coding genes. Furthermore, SRSFs bound RNAs also include exon‐exon junction reads, indicating that SRSFs remain associated with mRNPs even after completion of the splicing and serve as organizers of nuclear mRNPs (Müller‐McNicoll et al. 2016). In line with this observation, there are many reports that indicate SRSFs function in post‐splicing, including mRNA nuclear export and translation control (reviewed in Wegener and Müller‐McNicoll (2019)). Similar to yeast SR‐like proteins, SRSFs serve as adaptor proteins for the mRNA export receptor NXF1‐NXT1 in mammals (Hargous et al. 2006; Lai and Tarn 2004; Tintaru et al. 2007).

Exon‐Junction complex (EJC).

During splicing, the exon junction complex (EJC) is deposited 20–24 nt upstream of the exon‐exon junction as a marker of splicing completion (Schlautmann and Gehring 2020). EJC is composed of three core components, eIF4AIII, RBM8A, and MAGOH. Splicing‐dependent EJC assembly and loading to the exon‐exon junction is mediated through the physical interaction between a spliceosome component, CWC22, and eIF4AIII (Alexandrov et al. 2012; Barbosa et al. 2012; Steckelberg et al. 2012). Once assembled, the EJC core remains associated with the mRNA until the pioneer round of translation in the cytoplasm (Schlautmann and Gehring 2020). Persistent EJC binding to the mRNA is mediated by the RBM8A‐MAGOH heterodimer that locks eIF4AIII, a DEAD‐box ATPase, on the mRNA (Andersen et al. 2006; Bono et al. 2006). Once associated with an mRNA, the EJC core acts as an interaction platform for a variety of factors to direct events that include mRNA export and nonsense‐mediated decay (NMD) (Hug et al. 2016; Woodward et al. 2017). Purification of EJC‐bound mRNPs from human cells demonstrated that the EJC forms super‐assemblies on the mRNA that are important for the organization of the compacted higher‐order structure of the nuclear mRNPs (G. Singh et al. 2012).

THO/TRanscription‐EXport (TREX) Complex.

TREX is an evolutionarily conserved complex composed of the THO complex and other associated factors with roles in genomic stability, transcription, and export (Luna et al. 2019). The THO complex in yeast is composed of Tho2, Hpr1, Mft1, Thp2, and Tex1 (Luna et al. 2012) that is recruited via interaction with transcription machinery, including phosphorylated CTD of RNAPII itself and/or Prp19 complex (Chanarat et al. 2011; Henke‐Schulz et al. 2024; Meinel et al. 2013). Recruitment of THO is particularly important for highly expressed, GC‐rich, and long genes, as deletion of THO components diminishes the expression level of these genes (Gómez‐González et al. 2011). The THO complex further acts as an interaction platform for factors in mRNPs, which includes the DEAD‐box RNA helicase Sub2, mRNA export adaptor protein Yra1, and SR‐like proteins, Gbp2 and Hrb1 (Hurt et al. 2004; Sträßer et al. 2002). Since these associated RBPs are involved in mRNA export, THO in complex with Sub2 and Yra1 is referred to as the TRanscription and EXport (TREX) complex. Yra1 as an adaptor for the mRNA export receptor Mex67‐Mtr2 is essential for mRNA transport through the NPC (Strässer et al. 2000; Strässer and Hurt 2000; Stutz et al. 2000). Yra1 has a paralogous gene Yra2 that, when overexpressed, can complement the lethality of YRA1 gene deletion (Zenklusen et al. 2001). Recently, another RBP (Yhs7/YHR127W) has been identified in THO complex‐bound mRNPs with some structural and functional similarity to Yra1, with Yra2 sharing positively charged IDRs and RNA annealing activity (Bonneau et al. 2023), but lacking the UAP56 binding motif observed in Yra1/ALYREF. Structural analysis of recombinant THO complex in yeast has revealed a homodimer with two binding sites for Sub2 and Yra1 (Peña et al. 2012; Schuller et al. 2020; Xie et al. 2021). Transcriptome‐wide analysis of RBP binding has further shown that both Sub2 and Yra1 associate more frequently with longer gene transcripts (Baejen et al. 2014), suggesting an increased necessity for these proteins on mRNAs of certain features, indicative of gene‐dependent mRNP architectures.

In addition to the THO/TREX complex acting in transcription and mRNA export, the complex plays a role in preventing DNA–RNA hybrids, known as R‐loops (Huertas and Aguilera 2003). R‐loops are harmful nucleic acid structures that cause DNA double‐strand breaks (García‐Muse and Aguilera 2019). It is hypothesized that THO complex‐mediated mRNP organization prevents mRNA from annealing to the single‐stranded DNA generated during transcription (Luna et al. 2024). In line with this concept, many RBPs related to mRNA biogenesis and export are also identified as R‐loop preventing factors (Luna et al. 2024). For example, the RBP Tho1 was identified as both a multi‐copy suppressor of the R‐loop‐mediated genome instability phenotype and a nuclear export defect caused by the deletion of the THO complex component, HPR1 (Jimeno et al. 2006; Piruat and Aguilera 1998). This suggests the multiple functions attributed to THO/TREX through the analysis of mutants may be the result of inefficient mRNP packaging, which can be overcome by the function of other packaging factors.

The THO complex in mammals is a tetramer of a six‐subunit complex that includes THOC1, THOC2, THOC3, THOC5, THOC6, and THOC7 (Pühringer et al. 2020). The yeast Sub2 DEAD‐box ATPase has two paralogs encoded in mammals, UAP56 and URH49 (also referred to as DDX39B and DDX39A) (Pryor et al. 2004). The homolog of yeast Yra1, ALYREF, engages the TREX complex via interaction with UAP56 and is recruited to transcripts co‐transcriptionally via the CBC component NCBP1 (Cheng et al. 2006). ALYREF further mediates interaction between TREX and EJC, supporting the organization of compacted nuclear mRNPs (Gromadzka et al. 2016; Pacheco‐Fiallos et al. 2023; Viphakone et al. 2019). In mammals, ALYREF knockdown shows only a modest mRNA export defect compared to NXF1 depletion (Hautbergue et al. 2009; Katahira et al. 2009), suggesting the existence of predicted redundant TREX components. UIF (Hautbergue et al. 2009), Chtop (Chang et al. 2013), Luzp4 (Viphakone et al. 2015), PDIP3, and ZC11A (Folco et al. 2012) have been identified as such functionally redundant factors, adding further to the complexity of mammalian mRNP compositions. The yeast Tho1 homolog, CIP29/SARNP, also associates with TREX through UAP56 and is implicated in mRNP packaging (Dufu et al. 2010).

Poly(A) binding proteins (PABPs).

Near the end of transcription, the 3′ end of the mRNA is cleaved and a poly(A) tail is synthesized (Boreikaitė and Passmore 2023; Rodríguez‐Molina and Turtola 2023). These processes are mediated by a multi‐complex cleavage and polyadenylation machinery, composed of subcomplexes, CPF, CFIA, and CFIB in yeast, and CPSF, CstF, CFIm, and CFIIm in humans. Nuclear poly(A) binding proteins are involved in these processes and contribute to controlling the length of the poly(A) tail (Rodríguez‐Molina and Turtola 2023; Stewart 2019; Wigington et al. 2014). These processes are highly linked to mRNP packaging and export with some components incorporated into mRNPs. For example, the yeast CFIB protein, Hrp1, shuttles between the nucleus and cytoplasm and is involved in a cytoplasmic mRNA decay pathway, NMD, indicating that Hrp1 associates with mRNP during 3′ processing and is exported to the cytoplasm as a component of mRNPs (González et al. 2000; Kessler et al. 1997). Recently, it has been shown that Hrp1 directly interacts with the mRNA export receptor, Mex67, and is involved in the quality control to ensure the export of properly 3′ processed mRNAs (Li et al. 2023).

The yeast genome encodes two essential poly(A) binding proteins, Nab2 and Pab1. The majority of Nab2 localizes in the nucleus with a central role in nuclear poly(A) tail length control (Turtola et al. 2021). Nab2 interacts with Yra1 and the mRNA export receptor Mex67; thus, it is considered a major constituent of nuclear mRNPs supporting mRNA export (Asada et al. 2023; Green et al. 2002; Iglesias et al. 2010). Pab1, while mainly cytoplasmic with functions in translation (S. H. Kessler and Sachs 1998), shuttles between the nucleus and cytoplasm with roles in poly(A) tail length control and mRNA export (Brune et al. 2005; Turtola et al. 2021). Because the pab1 nuclear import mutant only shows a defect in poly(A) tail length when the available Nab2 pool is limited, Pab1 likely has a minor role or regulates only a subset of genes in the nucleus (Turtola et al. 2021). In humans, the nuclear poly(A) binding protein PABPN1 plays a major role in poly(A) tail length control and is engaged with mRNPs in the nucleoplasm (Bear et al. 2003). The Nab2 ortholog ZC3H14 is also involved in poly(A) tail length control (Kelly et al. 2014). ZC3H14 physically interacts with the THO complex and is required for proper processing and quality control (Morris and Corbett 2018), suggesting a role in mRNP packaging, similarly to Nab2.

Core RBPs identified by mRNP‐SiMPull with the nuclear cap binding complex component Cbp80 were the SR‐like protein Npl3, the poly(A) binding protein Nab2, and the TREX associated component Yra1 (Figure 2A, see Box 1 and Figure 1 for functional descriptions and human counterparts). Among these, Npl3 was typically present as a single copy, while Nab2 varied from 1 to 4 molecules per mRNP, likely linked to the poly(A) tail length (Tudek et al. 2021; Viphakone et al. 2008). Yra1 displayed the most variation in stoichiometry, ranging from one to ~10 copies. Notably, TREX components (e.g., THO complex and the Sub2 DEAD‐box ATPase) specifically co‐occupied mRNPs that harbor multiple copies of Yra1 (Figure 2A). In mRNP‐SiMPull, mild crosslinking, buffer composition, and temperature are used to stabilize complexes and minimize changes post‐lysis; however, changes may occur post‐lysis causing underestimates of RBP stoichiometry and co‐localization in vivo. Still, mRNP‐SiMPull provides a means to measure such estimates and detect changes; for example, deletion of THO complex components led to a reduction in multi‐copy Yra1‐bound mRNPs, but not a decrease in the overall population of Yra1‐bound mRNPs. These data reveal, at least in yeast, that the TREX complex is not solely responsible for loading Yra1 into mRNPs, but rather has a central role in stabilizing mRNPs with increased Yra1 stoichiometry. Consistent with this observation, others have reported that mRNPs purified by affinity purification via the THO complex contain super‐stoichiometric amounts of Yra1 (Bonneau et al. 2023; Kern et al. 2023). Sequencing of the mRNAs associated with the THO complex and super‐stoichiometric Yra1‐bound mRNPs indicates these mRNPs are enriched for genes of above average length (Asada et al. 2023; Bonneau et al. 2023). Given that Yra1 has RNA–RNA annealing activity (Bonneau et al. 2023; Portman et al. 1997), one possible model is that multi‐copy Yra1 binding compacts nuclear mRNPs by facilitating RNA annealing, particularly for challenging templates such as long mRNAs. Indeed, super‐resolution microscopy to assess the configuration of long mRNAs within the nucleus showed that depletion of Yra1 can lead to the decompaction of the mRNA (Asada et al. 2023).

FIGURE 2.

[画像:FIGURE 2]

Nuclear mRNP heterogeneity related to gene and condition‐specific regulation. (A) Nuclear mRNPs in S. cerevisiae consist of a combination of core and variable components with varying stoichiometries for each. The THO complex is frequently enriched on a subset of mRNPs (e.g., longer mRNAs) and supports the formation of mRNPs with super‐stoichiometric Yra1. (B) The stoichiometry of Yra1, Npl3, and Nab2 is further increased at higher growth temperatures (30°C vs. 37°C) in S. cerevisiae with Yra1 supporting compaction of nuclear mRNPs at 37°C. During acute temperature shift to 42°C (heat shock), RBPs dissociate from the bulk of the mRNA, while mRNAs encoding heat shock genes associate with Mex67‐Mtr2, facilitating gene‐selective export under stress conditions. (C) In S. cerevisiae, selective export of mRNAs is established during glucose deprivation by re‐localization of the poly(A) binding protein Nab2. Typically diffuse in the nucleoplasm, under glucose withdrawal Nab2 forms nuclear condensates, trapping bulk mRNA to block export, while stress‐responsive gene mRNAs are exported through an unknown mechanism. (D) Selective export of viral mRNAs in mammalian cells during HSV‐1 infection is accomplished by co‐opting host export machinery. The TREX component ALYREF localizes in the nucleoplasm with enrichment in nuclear speckle under normal cell conditions. During infection, the viral protein ICP27 physically interacts with ALYREF, depleting it from nuclear speckles and bringing it to the viral replication compartment, leading to the inhibition of host cell mRNA export and promotion of viral mRNA for export.

The data emerging from mRNP‐SiMPull begins to address the heterogeneity of individual nuclear mRNPs and provides a means to interrogate how mRNP compositions are defined via the introduction of specific mutations or environmental conditions. The demonstrated difference in RBP stoichiometries adds an important dimension to consider in directing gene expression outcomes. For example, it was demonstrated by mRNP‐SiMPull that RBP stoichiometry is altered under different growth conditions in yeast (Asada et al. 2023). Specifically, the temperature used to grow S. cerevisiae in the lab often ranges from 25°C to 37°C, and under constant growth, the stoichiometries of Yra1, Npl3, and Nab2 were increased at 37°C vs. 25°C or 30°C, while THO complex components showed reduced stoichiometry at 37°C (Figure 2B). Importantly, RNA‐sequencing data were not significantly different in cells grown at these temperatures, demonstrating that the transcriptome remained constant while mRNP compositions changed (Asada et al. 2023). Given that temperature significantly impacts RNA structure, with an increase from 30°C to 37°C shown to significantly alter secondary structure in vitro (Wan et al. 2012), we speculate that altered RBP compositions are needed to counter thermal stress and RNA unfolding. For example, via the RNA–RNA annealing activity of Yra1 (Bonneau et al. 2023; Portman et al. 1997), elevated incorporation of Yra1 may prevent unfolding of the RNA, maintain a compacted mRNP conformation, and buffer the cell against changes in gene expression and allow for maintenance of cellular homeostasis.

In contrast, an acute temperature shift (e.g., 25°C ➔ 42°C) triggers a stress response in yeast that is associated with a bulk mRNA export block (Saavedra et al. 1996). Although the heat‐induced mRNA export block occurs for most genes, stress‐responsive mRNAs are rapidly exported to the cytoplasm under these conditions (Zander and Krebber 2017). Here, regulation of RBP composition is expected to establish stress‐induced selective export (Figure 2B), with reports indicating mRNA export adaptor proteins, as well as Mex67‐Mtr2, dissociate from most mRNAs causing their retention in the nucleus (Zander et al. 2016). Conversely, stress‐responsive mRNAs are rapidly induced and associate with Mex67‐Mtr2 without the need for adaptor proteins (Figure 2B), allowing for rapid export of these mRNAs (Zander et al. 2016). In this situation, homeostasis is not the goal, but rather rapid reprogramming of gene expression, which may be achieved by sequestering specific RBPs in the nucleoplasm. For example, in stress conditions, nuclear basket proteins Mlp1/2 are dissociated from the NPC and form aggregates in the nucleoplasm, where Nab2 and Yra1 are also located (Carmody et al. 2010). Similarly, during acute glucose deprivation in yeast, Nab2 forms condensates in the nucleus and sequesters mRNAs within, thus blocking their export (Figure 2C) (Heinrich et al. 2024). Although IDRs are often responsible for mediating phase separation (Martin and Holehouse 2020), and Nab2 has typical IDR domains (QQQP and RGG domains), deletion of these IDR domains does not impair the formation of the condensates, but rather leads to larger condensates. Instead, a mutation that disrupts a Nab2–Nab2 interaction within the RNA binding Zinc finger domain (Aibara et al. 2017) impairs condensate formation, leading to increased export of bulk RNA. Furthermore, while stress‐responsive mRNAs are rapidly exported during stress in wildtype cells, the severe condensate‐forming Nab2 IDR truncation mutant blocks even stress‐responsive gene export (Heinrich et al. 2024), highlighting a potential link between the properties of the condensate and transcript export mechanisms. Overall, these data from S. cerevisiae demonstrate that nuclear mRNP composition is a key factor in establishing the fidelity and specificity of gene expression, which is regulated in response to cellular conditions. Similarly to stress conditions in yeast (Figure 2B,C), viral infection in mammalian cells is another occasion wherein changes in mRNP composition dictate preferential nuclear export (Box 2).

BOX 2. Co‐Opting Host mRNA Export Machinery for Preferential Export of Viral RNA.

In human cells, alterations in the composition of nuclear mRNPs are known to occur in the context of disease, including viruses co‐opting RBPs for the processing and export of their own viral transcripts while also disrupting host mRNP formation and gene expression (Guha and Bhaumik 2021). For example, the ICP27 family protein in herpes simplex virus‐1 (HSV‐1) directly interacts with ALYREF to recruit NXF1‐NXT1 (Figure 3D), facilitating viral mRNA export (Chen et al. 2002; Koffa et al. 2001; Soto‐Machuca et al. 2025). Notably, while ALYREF usually localizes within nuclear speckles, during HSV‐1 infection it re‐localizes to a viral replication compartment (Chen et al. 2005), suggesting depletion of the available ALYREF pool for host cell mRNA export. Similarly, ICP27 homologs in other herpesviruses interact with TREX components, as well as the other NXF1‐NXT1 adaptor RBPs, including ALYREF (Boyne et al. 2008; Malik et al. 2004; Williams et al. 2005), UAP56 (Lischka et al. 2006), UIF (Jackson et al. 2011), CIP29/SARNP and Chtop (Schumann et al. 2016), and SR proteins (Ote et al. 2009). In the case of influenza A virus (IAV) infection, the non‐structural protein 1 (NS1), a major virulence protein encoded in the IAV genome, directly interacts with NXF1‐NXT1, and structural analysis revealed that this interaction inhibits the NXF1‐NXT1 association with FG‐nucleoporins, which is required for host mRNP, leading to an mRNA export block (Zhang et al. 2019). Although the detailed mechanism is not fully understood, the IAV mRNA can escape from this inhibition and is efficiently exported to the cytoplasm via the NS1‐binding protein (Zhang et al. 2024). Similar to NS1 in IAV, non‐structural protein 1 (Nsp1) in the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) interacts with NXF1 and inhibits the interaction of NXF1 with the adaptor protein ALYREF and nucleoporins, leading to the inhibition of host cell nuclear mRNA export (Zhang et al. 2021). The Nsp14 protein encoded in the SARS‐CoV‐2 also inhibits host cell mRNA export (Katahira et al. 2023). Nsp14 is a bifunctional viral replicase subunit, which is composed of the exoribonuclease and N7‐methyltransferase (N7‐MTase) domains. The N7‐MTase methylates GTP and produces m7GTP, which acts as a cap mimic, depleting functional CBC (Katahira et al. 2023). Together, these examples highlight how viral pathogenesis is supported through virus‐specific mRNP compositions established via interactions between viral proteins and host cell nuclear mRNP components.

Detailed measurements of individual mRNP compositions have not yet been performed in mammalian cells, but the stoichiometry of some major constituents has been estimated. Sequence‐based analyses of EJC binding sites in human cells showed that most exon‐exon junctions are occupied by the EJC (Singh et al. 2012), and given that human genes have a median of 8 introns, it can be estimated that at least 8 molecules of EJC could bind an mRNP. The EJC can also form oligomers in vitro with ALYREF, which may underlie interactions that could scaffold human nuclear mRNPs (Pacheco‐Fiallos et al. 2023). Mass‐spectrometry analysis of purified EJC‐bound and RNase‐resistant mRNPs composed of both nuclear and pre‐translating cytoplasmic mRNPs has further revealed that SR proteins are super‐stoichiometric compared to EJC core proteins, indicating a role for SR proteins in organizing nuclear mRNPs (G. Singh et al. 2012). In addition, cryo‐electron tomography (cryo‐ET) analysis of THO complex‐containing mRNPs isolated from human cells identified 1–3 THO tetramers decorating the mRNP surface (Pacheco‐Fiallos et al. 2023). Beyond these estimates, future work is needed to address mRNP compositions in metazoan systems, but we consider it likely that yeast and metazoan mRNP packaging paradigms are conserved, given the high level of RBP conservation, including conservation of biological function in some cases. For example, lethality of Sub2, Yra1, Mex67/Mtr2 loss of function can be rescued via their metazoan homologs UAP56, ALYREF, and NXF1/NXT1, respectively (Katahira et al. 1999; Strässer and Hurt 2000; Zhang and Green 2001).

Overall, the extent and mechanisms governing mRNP heterogeneity are not well understood, which is expected to arise from both dynamic changes over time and differential compositions dictated by gene features (Figure 3). For example, maturation events in the nucleus can lead to the incorporation or dissociation of RBPs from an mRNP, generating compositional heterogeneity at different stages (Figure 3A). In contrast, some gene‐specific transcripts may require different RBPs to aid in establishing gene expression patterns linked to the function of the encoding protein (e.g., highly expressed genes, Figure 3B). Intrinsic gene features, such as introns and gene length, are expected to be another source of heterogeneity as they require additional processing events (e.g., splicing) or organization (e.g., compaction of long transcripts) (Figure 3C,D). Additionally, events disrupting mRNP assembly—which may or may not be tied to gene features—also have the potential to impact compositions (e.g., R‐loop formation or mRNP compaction defect) (Figure 3E,F). Altogether, these scenarios demonstrate the many complicated layers potentially dictating mRNP compositional heterogeneity, which will need to be understood to faithfully describe gene regulation in both healthy and diseased cellular states.

FIGURE 3.

[画像:FIGURE 3]

Sources of mRNP compositional heterogeneity. The composition of mRNPs will vary over time and across the transcriptome. During maturation, mRNP composition will be altered by the addition or dissociation of RBPs ("heterogeneity by maturation step"). Additionally, the time each gene transcript spends at a particular maturation step (represented as the length of the arrows in the figure) may vary across genes, potentially serving as another source of mRNP heterogeneity. The genome also encodes a variety of genes with distinct features (e.g., GC content, introns, length, etc.) and these features will require unique RBP compositions to achieve gene‐specific regulation ("heterogeneity by gene feature"). For instance, compared to a general gene (A), other gene transcripts are expected to form unique mRNPs: (B) highly expressed genes may have a specific mRNP composition to achieve rapid export from the nucleus; (C) genes requiring differential processing (e.g., intron vs. intron‐less gene) may necessitate unique combinations of RBPs; (D) long mRNAs may require additional copies of specific RBPs to become sufficiently compact; (E) the same gene mRNA may form different mRNP compositions due to events arising during assembly or maturation; this is anticipated, for example, in genes with R‐loop‐prone sequences that may require R‐loop resolution and differential packaging to prevent re‐formation. (F) Additionally, defects in mRNP compaction at any stage of nuclear may be "repaired" by further RBP addition.

3. mRNP Packaging and Structure

One expected outcome of forming an mRNP in the nucleus is the establishment of an organized mRNA to aid the events of gene expression. Across species, nuclear mRNPs are consistently found to be compact particles. Early electron microscopy (EM) studies in C. tentans found the ~35 kb Balbiani ring mRNA is compacted ~200‐fold for nuclear export (Skoglund et al. 1983, 1986). Likewise, negative stain EM of isolated nuclear mRNPs from S. cerevisiae found particles with a fixed width of ~5 nm and ranging from 20 to 30 nm in length, correlating with transcript length (Batisse et al. 2009). Given ~1 kb of linear RNA has a length of ~340 nm and the average yeast mRNA is ~1.5 kb (Hurowitz and Brown 2003), this suggests at least 10‐fold compaction of mRNA within observed particles (Figure 4). Furthermore, the application of live‐cell microscopy and fluorescence in situ hybridization (FISH) has provided additional insights into the organization of mRNPs. For example, live cell imaging and tracking of single mRNPs of varying transcript lengths (~1–17 kb) in human cell lines reported diffusion coefficients in the nucleus that do not vary greatly with size, suggesting similarly sized particles with increased compaction of longer mRNAs (Mor et al. 2010). Single molecule FISH studies likewise demonstrated differing spatial organization throughout the life cycle of an mRNP in human cells, with actively translated mRNAs in the most open conformation and both nuclear and stress‐granule localized mRNAs being compacted (Adivarahan et al. 2018; Ashkenazy‐Titelman et al. 2022; Khong and Parker 2018). Alongside these FISH studies, biochemical and bioinformatic modeling (RIPPLiT and ChimeraTie) have suggested nascent and pre‐translation human mRNPs are compacted into linear rod‐like structures (Metkar et al. 2018). This is consistent with previous EM findings in C. tentans and S. cerevisiae , suggesting the compaction of nuclear mRNPs is a widely conserved phenomenon; however, underlying mechanisms governing mRNP packaging and compaction have remained largely uncharacterized.

FIGURE 4.

[画像:FIGURE 4]

Mechanisms promoting packaging and compaction of nuclear mRNPs. Data demonstrate nuclear mRNPs are compacted particles supported by RNA–RNA, RNA–protein, and protein–protein interactions. Critical aspects of this organization and compaction are expected to include: (A) physical interactions among co‐occupied RBPs to bring RBP‐bound regions close together; (B) RNA annealing directed by RBPs with positively charged IDR domains; (C) RNA structure involving local folding, long‐range base pairing, three‐dimensional conformations of RNA secondary structure; (D) protein and RNA modifications influencing RBP association and RNA structural organization.

A major hurdle in understanding mRNP packaging and compaction is the difficulty in capturing structural information for this very diverse class of protein‐RNA complexes. In 2023, two studies provided key advancements in the structural characterization of nuclear mRNPs from yeast and human (Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023). Both studies found the conserved TREX complex is central to mRNP packaging, building upon previous crystal and cryo‐EM structures determined for the TREX complex (Pühringer et al. 2020; Ren et al. 2017; Schuller et al. 2020; Xie et al. 2021). Specifically, cross‐linked and mildly RNase‐treated human mRNPs isolated via pulldown of the THO complex were found by cryo‐EM to be globular particles with a median diameter of 45 nm (ranging from 30 to 70 nm), suggesting the mRNA within would be compacted ~50‐fold on average (Pacheco‐Fiallos et al. 2023). These particles were coated by TREX tetramers on the surface, aligning well with a previously determined structure (Pühringer et al. 2020), as well as in agreement with cross‐linking mass spectrometry performed on the particles (Pacheco‐Fiallos et al. 2023). The structure shows the DEAD‐box ATPase UAP56 and mRNA export adaptor ALYREF most proximal to the core of the mRNP, presumably to make contacts with the packaged RNA, which was not resolved (Pacheco‐Fiallos et al. 2023). Moreover, this study also solved a cryo‐EM structure of a recombinant ALYREF‐Exon‐Junction‐Complex (ALYREF‐EJC), which forms oligomers, suggesting ALYREF may promote multivalent interactions with EJC and RNA as a means for recognizing and organizing mRNPs (Pacheco‐Fiallos et al. 2023). ALYREF‐EJC interactions were also supported by crosslinks in the native complexes, suggesting interactions reconstituted in vitro occur in a similar manner within mRNPs in vivo. These data position ALYREF as a key mRNP packaging factor for EJC‐bound mRNAs, bridging the interaction to UAP56 and THO on the surface of the mRNP (Pacheco‐Fiallos et al. 2023). As such, ALYREF and EJC are envisioned to be key organizing RBPs within mRNPs, aiding in the compaction of mRNPs through protein–protein interactions, as illustrated in Figure 4A.

Yeast TREX‐containing mRNPs were also found to be compact by cryo‐ET (Bonneau et al. 2023), but of more heterogeneous shape and size than isolated human particles (Pacheco‐Fiallos et al. 2023), which may be a product of biological difference or difference in experimental conditions for isolation. Single‐particle cryo‐EM analysis could not resolve these mRNPs, leaving open questions as to what ways TREX engagement may or may not differ from human. Nonetheless, cross‐linking mass spectrometry (XL‐MS) analysis of the mRNPs found many crosslinks consistent with the known structure of the THO complex, Sub2, and Cbp80‐Cbp20, as well as intra‐links consistent with the known oligomerization of poly(A)‐binding proteins (Aibara et al. 2017; Bonneau et al. 2023; Ren et al. 2017; Schuller et al. 2020). XL‐MS also identified Yra1, the ortholog of ALYREF, as a hotspot for both intra‐ and interlinks (Bonneau et al. 2023). This suggests multiple copies of Yra1 are in proximity with itself and other network proteins, consistent with single‐molecule imaging data finding Yra1 in high copy number within THO complex‐occupied nuclear mRNPs (Asada et al. 2023). This supports Yra1, similarly to ALYREF, as an organizing RBP aiding in the compaction of mRNPs through multivalent protein interactions (Figure 4A). Furthermore, interactions between Yra1 and other network proteins—Tho2 and Yhs7—were identified that contain positively charged IDRs and are capable of robust RNA‐annealing capacity in vitro (Bonneau et al. 2023; Portman et al. 1997). With these data, an "IDR network model" of mRNP packaging was proposed wherein positive IDRs extend from a network of protein–protein interactions to further promote mRNA compaction via interaction of the IDRs with the negatively charged RNA backbone (Bonneau et al. 2023), as illustrated in Figure 4B. It is well established that IDR domain proteins can form phase‐separated condensates via weak multivalent interactions with RNA (Alberti and Hyman 2021; Chong et al. 2018; Martin and Holehouse 2020), which, if occurring in the context of nuclear mRNP processing, may further enforce the compacted nuclear mRNP conformation.

While yeast lack an EJC, and thus do not exactly fit with the proposed model of ALYREF‐EJC oligomerization driving human mRNP organization (Pacheco‐Fiallos et al. 2023), in both cases published data provide a compelling case for the importance of Yra1/ALYREF in packaging mRNA through multiple mechanisms. First, the RNA annealing capacity of the IDRs is conserved, with both proteins being able to bind and anneal RNA (Figure 4B) (Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023; Portman et al. 1997). Second, Yra1 and ALYREF are both able to promote multivalent protein–protein interactions (Figure 4A) (Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023). Third, super‐resolution microscopy shows decompaction of mRNAs at higher growth temperatures when Yra1 is depleted (Asada et al. 2023), and finally, metazoan ALYREF can complement the lethality of a YRA1 loss of function (Strässer and Hurt 2000). Altogether, these data point toward a conserved role for Yra1/ALYREF in coordinating the packaging of mRNPs with partner RBPs and associated factors (e.g., THO/TREX in yeast; EJC with THO/TREX in human).

In a model where protein–protein and protein–RNA interactions promote mRNP packaging, it is expected that other RBPs also contribute to mRNP compaction. For example, it has been shown that the Zn finger domain of the yeast nuclear poly(A) binding protein Nab2 forms an RNA‐dependent dimer (Aibara et al. 2017). Given that Nab2 binds internal gene regions beyond the poly(A) tail (Tuck and Tollervey 2013), and is present in mRNPs as 1–4 molecules (Asada et al. 2023), it is possible that Nab2 may also compact RNA through dimerization. Indeed, it has been shown that recombinant Nab2 induces compaction of mRNA in vitro (Aibara et al. 2017). Additionally, interactions between UAP56 and the RBP SARNP are suggested to contribute to mRNP compaction (Xie et al. 2023). The crystal structure of the SARNP‐UAP56‐RNA complex identified a conserved helix within SARNP, named the DDX39B interacting motif (DIM), which mediates an interaction with UAP56. SARNP contains five DIMs, which are also found within Tho1, the yeast homolog of SARNP, with structural data indicating that Tho1/SARNP may bridge multiple copies of Sub2/UAP56, which in turn would lead to the organization and compaction of the associated mRNA (Xie et al. 2023). Together, given the diversity of mRNP compositions, it is expected that mRNP packaging emerges in part from a set of interactions driven by core factors (e.g., Yra1/ALYREF, THO/TREX, EJC, SR proteins, PABPs) that vary across individual mRNPs based on the complement of co‐occupied RBPs.

While these recent advancements have been critical to building an understanding of the structural organization of proteins within mRNPs, they notably do not resolve the RNA nor otherwise characterize its structure within the mRNPs. RNA structure is expected to play an important role in mRNP packaging through several different elements, including secondary structure and long‐range base pairing, as well as by influencing RBP binding events (Figure 4C). While there have been numerous advancements in methods to map in vivo RNA structure, reviewed in (Arney et al. 2024; Cao et al. 2024; Mustoe et al. 2023; Wang et al. 2021), determining nuclear mRNA structures remains challenging because a majority of transcripts are cytoplasmic at steady state. Thus, cytoplasmic structures outweigh the contributions of nuclear structures in ensemble data, potentially obscuring structural elements unique to the nuclear population. Still, in recent years, progress has been made in the characterization of nuclear mRNA structure, both for specific transcript targets (Bubenik et al. 2021; Kumar et al. 2022) and for global targets using nuclear isolation in Arabidopsis thaliana (Liu et al. 2021) and mammalian cell lines (Sun et al. 2019). These have been able to identify changes in RNA structure tied to particular RBP binding events, but in general do not show dramatically different structures across cellular compartments, in contrast to the degree of compaction that has been observed for nuclear mRNPs. Likewise, most recently, a technique was developed to track co‐transcriptional RNA structure in live yeast cells (CoSTseq), which found nascent mRNA base pairing strongly resembles that of mature cytoplasmic structures, suggesting nascent folding upon exiting RNAPII is similar to co‐translational refolding after exiting the ribosome (Schärfen et al. 2025). While this supports similar local structure formation co‐transcriptionally and co‐translationally, again it does not reconcile how nuclear mRNPs become compacted to the degree observed by electron microscopy (Batisse et al. 2009; Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023; Skoglund et al. 1986), necessitating further characterization of RNA structure within nuclear mRNPs.

RNA modification is emerging as an important layer of regulation governing mRNA metabolism (Boo and Kim 2020; Gilbert and Nachtergaele 2023; Sun et al. 2023), which must also be considered in the formation and regulation of mRNPs, alongside the better understood role of posttranslational modifications in regulating RBPs (reviewed in Goswami et al. (2024); Velázquez‐Cruz et al. (2021)). Although there is no direct evidence yet, we postulate RNA modifications will influence mRNP packaging through impacts on RNA structure and RBP binding. For example, pseudouridine modifications are present in pre‐mRNA near splice sites and have been demonstrated to impact splice site choice (Martinez et al. 2022). As such, there is likely an active role for both protein and RNA modification in mRNA processing and mRNP assembly (Figure 4D), which could further contribute to heterogeneity in mRNPs, dictating differential RBP loading events and outcomes (Figures 2 and 3). Overall, much remains to be explored as to how RBP and RNA modifications are connected to mRNP compositions, conformations, cellular and environmental growth conditions, and ultimately nuclear processing and gene expression outcomes.

4. Dynamics of mRNP Assembly, Maturation, and Nuclear Export

As described in the previous sections, mRNPs must be processed and packaged before ultimately being exported through an NPC (Figure 1). The molecular details of the individual processing steps are well characterized, including 5′ capping, splicing of introns, 3′ cleavage, and polyadenylation, and written about extensively in other reviews (Boreikaitė and Passmore 2023; Carrocci and Neugebauer 2024; Gilbert and Nachtergaele 2023; Ramanathan et al. 2016; Rambout and Maquat 2020; Rodríguez‐Molina et al. 2023; Senn and Hoskins 2024; Shenasa and Bentley 2023). However, the spatial and temporal dynamics of mRNP assembly and maturation, including the coordination of distinct events with respect to each other, are less well understood. Recent advancements employing live‐cell imaging and cryo‐EM have now provided significant insights into the order of mRNP assembly and maturation leading to docking and export through an NPC.

4.1. mRNP Assembly and Maturation Dynamics

At the transcription site, nascent mRNA processing and packaging is directed by RBPs, many of which are known to bind the C‐terminal domain (CTD) of RNAPII co‐transcriptionally in a phosphorylation‐dependent manner (Harlen and Churchman 2017; Hsin and Manley 2012; Singh et al. 2022; Venkat Ramani et al. 2021), including TREX complex components (MacKellar and Greenleaf 2011; Meinel et al. 2013). Temporal models of co‐transcriptional processing and mRNP assembly are based largely on known functions of RBPs, binding site locations within transcripts, and Chromatin immunoprecipitation (ChIP) density at active genes. For example, it may be assumed that RBPs with a 3′ bias in the mRNA would be recruited later than those showing 5′ proximal peaks in binding, but in most cases direct evidence of recruitment timing is lacking. As such, many questions remain as to how mRNP assembly is coordinated in vivo, including the requirement for varied processing based on gene features (e.g., promoter, transcript length, etc.), as illustrated in Figure 3. This is in large part due to the technical challenges of tracking mRNP assembly in vivo at a single transcription site.

To address this, we recently employed a live‐cell imaging assay that can monitor temporal dynamics of co‐transcriptional RBP recruitment to an inducible gene array in S. cerevisiae (Wechsler et al. 2025). This was motivated by previous work employing tandem gene arrays in mammalian cells to visualize enrichment of RBPs at transcription sites (Brody et al. 2011; Hochberg‐Laufer et al. 2019; Janicki et al. 2004). Using inducible gene arrays, with two different promoters and the same coding sequence (GFA1), recruitment of endogenously tagged proteins was observed at active transcription sites and arrival times quantified for a wide variety of proteins with roles in transcription, mRNP processing, and mRNP packaging, including TREX complex components (Wechsler et al. 2025). Notably, this demonstrated Yra1 was among the earliest factors recruited to the transcription site, with recruitment occurring prior to and independent of the THO complex. Furthermore, recruitment was delayed in cbp80Δ as well as when the RRM domain of Yra1 is deleted (Yra1ΔRRM). The RRM domain in Yra1 was implicated previously as a hot spot for protein–protein interactions (Bonneau et al. 2023), and human structural data shows a direct interaction between the ALYREF RRM domain and the cap binding complex (Clarke et al. 2024). This suggests a model where the early arrival of Yra1 is facilitated by protein interactions, including between Yra1 and CBC, as well as the RNAPII CTD (MacKellar and Greenleaf 2011), poising Yra1 to immediately engage the emerging nascent RNA to aid productive elongation and mRNP packaging via RNA annealing.

It is not known if the temporal dynamics of ALYREF are the same or different in metazoan systems, given the central role of splicing and the EJC in mRNP assembly and compaction (Pacheco‐Fiallos et al. 2023). However, the arrival timing of Yra1 aligns well with structural data in humans, placing ALYREF at the mRNP core (Pacheco‐Fiallos et al. 2023), the role of THO in promoting higher Yra1 stoichiometries as determined by mRNP‐SiMPull (Asada et al. 2023), and the emerging model of mRNP assembly centered on a protein–protein interaction network of IDR‐containing proteins (Bonneau et al. 2023). It is also notable that the early arrival of Yra1 and the initiation of timely mRNA packaging via THO/TREX may be linked to the prevention of R‐loops (Infantino and Stutz 2020; Luna et al. 2019). Indeed, mutations in many different mRNP biogenesis and processing components increase R‐loop formation, and it is suggested that mRNP packaging prevents R‐loop formation by preventing the RNA from hybridizing with single‐strand DNA (Luna et al. 2024). Interestingly, it was recently demonstrated that ALYREF can directly bind DNA–RNA hybrids and R‐loops in vitro, and together with UAP56 resolve R‐loops (Bhandari et al. 2024), raising the possibility of RBP‐directed events during mRNP packaging that actively resolve R‐loops. We expect this to be an active area of future research given the links between R‐loops, gene expression, genome instability, and human disease (Aguilera and Aguilera 2025; Beghѐ et al. 2025; Mudiyanselage et al. 2025; Stötzel et al. 2025).

Once transcription terminates and transcripts are cleaved and polyadenylated, the dynamics of subsequent maturation events within the nucleus leading to export are generally unclear. It is expected this entails the association and dissociation of varied RBPs from the mRNPs, but these events are difficult to capture (Figure 1). In yeast, nuclear residencies are typically quite short, with transcripts thought to be exported rapidly after release. In mammalian cells, significant processing is reported to occur following transcript release from the transcription site, including within nuclear speckles (Figure 1), though many open questions remain regarding the frequency, dynamics, and mechanisms governing these post‐transcriptional processing events (Carrocci and Neugebauer 2024; Choquet et al. 2025; Shenasa and Bentley 2023; Faber et al. 2022; Galganski et al. 2017; Hasenson and Shav‐Tal 2020). Similarly, SR‐proteins located at nuclear speckle have been shown to mediate gene‐specific regulation by retaining mRNAs with GA‐rich RNA sequences, thus buffering the expression of a class of genes with disordered low‐complexity domains (LCDs) that can be toxic when expressed at high levels in human cells (Faraway et al. 2023). Most recently, it was demonstrated that under conditions of transcriptional inhibition in human cells, mRNAs accumulate in nuclear speckles bound by ALYREF and NXF1, where they are held until mRNA export is reinitiated once the inhibition is lifted (Williams et al. 2025). The TREX complex is known to be enriched in nuclear speckles (Akef et al. 2013; Dias et al. 2010; Masuda et al. 2005; Wang et al. 2018) and data suggest roles in regulating the storage and release of transcripts from speckles (Akef et al. 2013; Dias et al. 2010; Teng and Wilson 2013; Wang et al. 2018). These observations suggest that THO/TREX and other RBPs may engage mRNAs in nuclear speckles to maintain mRNA compaction, protecting these complexes from degradation by the RNA exosome and other RNA decay machinery. More broadly, it suggests that nuclear residence time is going to be highly variable across transcripts and regulated in response to cellular conditions.

Toward further understanding nuclear mRNA processing dynamics, two recently developed methods employ metabolic labeling to characterize the dynamics of the mRNA lifecycle transcriptome‐wide in mammalian cells (Choi et al. 2024; Ietswaart et al. 2024). With TimeLapse‐seq (Ietswaart et al. 2024), cells are pulsed labeled over a time course, and RNA is biochemically purified and sequenced from chromatin, nucleus, cytoplasm, and polysomes, which in combination with mathematical modeling, enabled evaluation of transcript half‐lives in each compartment as well as estimated rates of nuclear export, polysome loading, and turnover. This demonstrated vast kinetic heterogeneity among transcripts and identified groups of genes with notable trends, like high rates of nuclear degradation. Choi et al. (2024) employ a pulse‐chase time course to label RNA, crosslink to preserve RNA–protein interactions, pull down polyadenylated RNAs, and then use mass spectrometry to determine RBPs associated with labeled RNAs at each time point. From this, they identified seven clusters of RBPs with binding patterns ranging from early (I) to late (VII), with many trends aligning with known RBP functions. Of note, they identify ALYREF and UAP56, as well as core EJC proteins, as relatively late binders (cluster V) that join after the major export factor NXF1 (Choi et al. 2024). Currently, with the bulk nature of the experiment and use of oligo‐dT to perform the isolations, it remains to be seen if these patterns of RBP binding represent an alternate pathway of mRNP assembly or reflect a technical bias for a particular population of mRNAs due to the purification scheme and/or transcript features. Overall, these observations of mRNP dynamics involving nuclear speckles (Williams et al. 2025), kinetic heterogeneity across transcript processing (Ietswaart et al. 2024), and alternate patterns of RBP binding (Choi et al. 2024; Tuck and Tollervey 2013) underscore the need for more work to understand how variation in mRNP assembly and maturation come together to regulate gene expression.

4.2. Docking and Remodeling for Nuclear Export

Ultimately, nuclear mRNPs must be exported through NPCs to continue along the gene expression pathway. Export competency emerges from upstream processing events that link mRNA maturation (e.g., m7G cap, poly(A) tail, exon junctions) with key RBPs that serve as adaptors for the major export receptor heterodimer (NXF1‐NXT1 in humans, Mex67‐Mtr2 in yeast). The presence of the export receptor ultimately provides access to the NPC, with export efficiency further being regulated by other RBP‐directed binding events with the nuclear basket and nucleoporins (Bensidoun et al. 2021). Interestingly, in yeast, nuclear basket formation was found to be influenced by RNA metabolism, and a subset of RNAs was found to be associated with basket‐less NPCs, suggesting an alternative route of export through pores lacking a basket (Bensidoun et al. 2022). The RNAs in this population were enriched for shorter transcripts with shorter poly(A) tails, suggesting possible selectivity in export, but the mechanisms conferring export in basket‐less NPCs require investigation.

Single particle tracking studies have followed mRNP export kinetics in both yeast and mammalian cells, finding that in both cases mRNPs often scan the nuclear periphery and dock at the nuclear basket of the NPC prior to export (Grünwald and Singer 2010; Mor et al. 2010; Saroufim et al. 2015; Smith et al. 2015). The purpose and mechanism of this scanning and docking at the pore are not entirely understood, but may be a mechanism conferring selectivity (Bensidoun et al. 2021). In yeast, the poly(A) binding protein, Nab2, physically interacts with the nuclear basket component, Mlp1/2 (Fasken et al. 2008; Green et al. 2003). Disruption of the Nab2‐Mlp1/2 interaction impairs mRNP scanning and docking, causing frequent release of mRNPs back into the nucleoplasm (Saroufim et al. 2015). This indicates that interactions between mRNP components and the nuclear basket support productive docking of the mRNPs onto the pore for export. Depletion of the orthologous human nuclear basket protein TPR disrupts mRNA export, particularly for short genes with few introns, suggesting a conserved role of the nuclear basket in facilitating mRNP interactions with the pore (Aksenova et al. 2020; Lee et al. 2020).

Along the mRNA export path, nuclear mRNPs must be remodeled for use in the cytoplasm and to infer directionality to the export process. This remodeling in part occurs at the cytoplasmic side of the NPC (Köhler and Hurt 2007); however, recent studies also suggest that mRNP remodeling takes place within the nucleus and at the nuclear basket of the NPC. Specifically, the THO complex coats the surface of human mRNPs, with recent biochemical and structural analyses proposing a model where the THO complex is dissociated through the competitive binding of SARNP to an overlapping binding site on UAP56 (Hohmann et al. 2024). This establishes conditions for a second proposed remodeling at the nuclear basket mediated by the TREX‐2 complex. TREX‐2 is an evolutionarily conserved complex that localizes to NPCs by association with the nuclear basket (Fischer et al. 2002; Umlauf et al. 2013). In yeast, TREX‐2 is composed of Sac3, Thp1, Sus1, Cdc31, and Sem1, while in humans the subunits are GANP, PCID2, ENY2, DSS1, and CETN2 or CETN3. Mutation of TREX‐2 causes nuclear mRNA accumulation, indicating that TREX‐2 mediates mRNP export (Ellisdon et al. 2012). Most recently, structural studies identified an interaction between TREX‐2 and UAP56/Sub2 as key to the remodeling of mRNPs for export at the pore, in both human and yeast (Hohmann et al. 2024; Xie et al. 2025). These studies structurally characterized the TREX‐2 and UAP56/Sub2 interaction by cryo‐EM, and in both cases identified a conserved loop in a TREX‐2 subunit (GANP/Sac3) that stimulates the ATPase activity of UAP56/Sub2 and promotes the release of UAP56/Sub2 from RNA (Hohmann et al. 2024; Xie et al. 2025). Additionally, a complex was recently identified in human cells consisting of TREX‐2 subunits PCID2 and DSS1 with an alternative scaffold subunit, LENG8, that is a paralog of GANP (Clarke et al. 2025). This complex, termed TREX‐2.1, was also found to bind to UAP56, stimulating its ATPase activity and RNA release through the same conserved trigger loop as GANP (Clarke et al. 2025). In contrast to TREX‐2, which is localized predominantly to NPCs, TREX‐2.1 is localized throughout the nucleoplasm, suggesting it may act to regulate UAP56 activity in an alternative context such as splicing or decay (Clarke et al. 2025). While LENG8 has an ortholog (THP3) in S. cerevisiae, it remains to be seen whether the formation of a TREX‐2.1‐like alternative complex and stimulation of Sub2 activity are conserved.

Overall, the binding and stimulation of Sub2/UAP56 by TREX‐2 suggests a model wherein TREX‐2 triggers mRNP export via removal of the DEAD‐box ATPase UAP56/Sub2 at the nuclear basket (Figure 1) (Hohmann et al. 2024; Xie et al. 2025). This indicates perinuclear scanning may be a byproduct of unproductive UAP56/Sub2–TREX‐2 binding at the NPC, due to lack of UAP56/Sub2 incorporation in mRNPs and/or lack of available TREX‐2 at those pores, perhaps making this interaction a means of selectivity for properly matured mRNPs. These data support a conserved mechanism for unloading of UAP56/Sub2 from mRNPs at the nuclear face of the NPC for export and, critically, bridge the roles of TREX in mRNP packaging to export competency and remodeling at the NPC to regulate nuclear export.

4.3. Loading the mRNA Export Receptor for Export Through an NPC

The mRNA export receptor, Mex67‐Mtr2/NXF1‐NXT1, mediates interaction of mRNPs with the central channel of the NPC, facilitating export into the cytoplasm. One long‐standing model is that the export receptor is loaded onto the mRNA co‐transcriptionally via interaction with adaptor proteins. This is supported by the data showing Mex67 and NXF1 can be detected by ChIP (Chen et al. 2019; Gwizdek et al. 2006), and in the case of NXF1, CLIP‐seq analysis showed detection of exon‐intron sequence reads, indicating that NXF1 can bind to pre‐mRNA during processing (Müller‐McNicoll et al. 2016). However, recent advances in imaging techniques have suggested a model where Mex67‐Mtr2 independently functions at the NPC, mediating export at the pore upon encountering mRNPs. In yeast, fluorescent correlation spectroscopy (FCS) analysis to assess the diffusion coefficient of the fluorescently tagged protein revealed that Mex67 diffusion behavior is more closely related to a free protein in contrast to a large molecular assembly like an mRNP (Derrer et al. 2019). Moreover, the lethality of a MEX67 gene deletion can be rescued by expressing a fusion of Mex67 and the nucleoporin Nup116, suggesting that the essential function of Mex67 occurs at the NPC, rather than loading being necessary prior to docking of the mRNP to the pore (Derrer et al. 2019). Consistent with these observations, live imaging to track single mRNAs in the mex67‐5 mutant showed a greater impact on mRNP cytoplasmic release than docking and translocation (Smith et al. 2015). Furthermore, single‐molecule analyses of mRNPs showed that Mex67 is rarely associated with mRNPs bound by the export adaptor proteins Yra1, Nab2, and Npl3 (Asada et al. 2023). In addition, RNA‐independent localization of NXF1 to NPCs is observed in mammalian cells, and like in yeast, the diffusion rate of NXF1 within the nucleoplasm showed that NXF1 behaves as a free protein rather than a large complex (Ben‐Yishay et al. 2019). These data strongly indicate mRNP‐binding and the promotion of mRNA export under steady‐state growth conditions are most commonly occurring at NPCs (Figure 1). Nonetheless, it remains possible that Mex67‐Mtr2/NXF1‐NXT1 functions to support mRNP export via distinct modes that may be gene‐specific. For example, as noted previously, stress‐responsive mRNAs associate with Mex67‐Mtr2 without the need for adaptor proteins, allowing for rapid export of these mRNAs (Figure 2B) (Zander et al. 2016). In the case of stress, where and when Mex67 joins the mRNP in relation to mRNP assembly at transcription sites vs. binding to NPCs is not known.

5. Conclusions and Future Perspective

There has been significant progress made in recent years toward understanding nuclear mRNPs. This includes the application of high‐throughput sequencing and proteomics approaches to shed light on a previously unappreciated breadth and diversity of RBPs and mRNA–protein interactions, highlighting the multifaceted heterogeneity of mRNPs across genes, gene expression stages, and environmental conditions. This in turn generated further inquiry into the composition, organization, and dynamics of mRNPs, addressed in subsequent studies using diverse techniques, as detailed here. Together, this has provided a more comprehensive view of nuclear mRNPs, with studies across species converging on key findings. For example, both yeast and human nuclear mRNPs are found to be compact particles (Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023), with the RNA annealing TREX protein Yra1/ALYREF playing an important role in organizing them (Asada et al. 2023; Bonneau et al. 2023; Pacheco‐Fiallos et al. 2023). Furthermore, a conserved mechanism was identified for TREX‐2 mediated removal of Sub2/UAP56 at the nuclear face of the NPC, promoting directional export of nuclear mRNPs (Aksenova et al. 2020; Hohmann et al. 2024; Xie et al. 2025). Still, many open questions remain, particularly around mechanisms governing the generation of mRNP heterogeneity (across genes, space, time, environmental conditions, etc.), and—importantly—how this heterogeneity contributes to gene regulation. Two major themes for future investigation include:

5.1. Characterizing Nuclear mRNP Heterogeneity

As supported by recent works, including those discussed above, transcriptome‐wide nuclear mRNPs vary not only in their mRNA sequences but also in protein composition, size, and organization. While published research has begun to characterize this heterogeneity, there is still much to know about the mechanisms responsible for generating differential nuclear mRNP features and how they contribute to differential gene expression outcomes. It is expected that gene and transcript features (e.g., promoter, sequence, length, presence of introns, RNA modifications, polyA‐tail length) play a central role, but a comprehensive characterization is lacking and will be important to address in future work. This motivates the need for improved techniques to interrogate mRNP composition and structure in a gene‐specific manner at single molecule resolution.

In addition to transcriptome‐wide heterogeneity, there is diversity across the mRNPs produced from the same gene, including compositional changes over time as mRNPs progress through gene expression, changes dictated by external environmental conditions (e.g., stress), and diversity arising from stochastic events during gene expression (e.g., splicing order, transcription‐replication conflict, presence of an R‐loop, error in processing, etc.). This heterogeneity is exemplified by changes in S. cerevisiae nuclear mRNP compositions at moderately elevated temperature (37°C) observed with mRNP‐SiMPull despite a constant transcriptome (Asada et al. 2023). We expect that to fully understand gene expression regulation, an understanding of the population of mRNPs coming from individual genes is needed.

These open questions necessitate improved technologies to interrogate the composition and architecture of individual mRNPs with gene specificity. Our group is currently working to implement a gene‐specific mRNP‐SiMPull, extending the capabilities of our previous work to characterize mRNP composition for transcripts of individual genes. Furthermore, the extension of approaches to structurally characterize mRNPs, such as cryo‐EM, to characterize mRNPs at a gene‐specific level is critical to better understand the relationship between transcript features and structure. Observed heterogeneity in particle size and shape at present cannot be correlated to any gene features, so it is not known how different aspects of the transcript contribute to overall packaging and conformation(s).

5.2. Organizing Principles of RNA Within Nuclear mRNPs

Many open questions need to be addressed with respect to the organization of mRNA in mRNPs and the role RNA structure plays in mRNP packaging. These include whether mRNAs have a repeating structure/organization that is reliant on length and/or sequence features, whether compaction is driven largely by intramolecular interactions or RBPs, and whether mRNA structure is actively directing gene expression outcomes. The most recent efforts in probing yeast and mammalian nuclear mRNAs have found high levels of structural similarities to cytoplasmic transcripts (Schärfen et al. 2025; Sun et al. 2019). This suggests compaction may be accomplished through long‐range contacts or tertiary structures not captured with these structure probing experiments, or that additional local base pairing interactions beyond those observed may be highly dynamic or heterogeneous across particles, making them difficult to capture, even with current depths of sequencing. As such, further data characterizing overall nuclear mRNA conformations will help to inform how this compacted packaging is achieved. Finally, with emerging data suggesting previously unappreciated breadth of mRNA base modifications and the advent of new technologies to map modified sites transcriptome‐wide (Boo and Kim 2020; Gilbert and Nachtergaele 2023; Sun et al. 2023), it will be necessary to explore how these modifications influence nuclear mRNP composition, organization, and dynamics, as they are expected to influence all of these aspects to varying degrees.

Overall, we expect that continued advances in gene‐specific interrogation methods for mRNPs will reveal mechanisms that generate their heterogeneity and better understanding of how these diverse particles shape gene expression regulation. Such insights will ultimately provide fundamental principles of RNA packaging and regulation, deepening our understanding of how mRNP diversity contributes to gene expression outcomes.

Author Contributions

Theresa Wechsler: conceptualization (equal), writing – original draft (equal), writing – review and editing (equal). Ryuta Asada: conceptualization (equal), writing – original draft (equal), writing – review and editing (equal). Ben Montpetit: conceptualization (supporting), funding acquisition (lead), supervision (lead), writing – original draft (supporting), writing – review and editing (supporting).

Conflicts of Interest

The authors declare no conflicts of interest.

Related WIREs Articles

The organization and regulation of mRNA‐protein complexes

Nuclear sorting of RNA

Choosing the right exit: How functional plasticity of the nuclear pore drives selective and efficient mRNA export

Nuclear quality control of RNA polymerase II transcripts

Dynamics and kinetics of nucleo‐cytoplasmic mRNA export

Acknowledgments

We are grateful to all present and past members of the Montpetit Lab for their discussion and feedback on this work. Figures were created in BioRender: https://BioRender.com/hsl6q36.

Wechsler, T. , Asada R., and Montpetit B.. 2025. "Mixed Messages: Dynamic and Compositional Heterogeneity of Nuclear Messenger Ribonucleoprotein (mRNP) Complexes." Wiley Interdisciplinary Reviews: RNA 16, no. 6: e70032. 10.1002/wrna.70032.

Editor‐in‐Chief: Jeff Wilusz

Funding: The Montpetit Laboratory is supported by the US National Science Foundation under award number 2140761 and the National Institute of General Medical Sciences under Award Number R35GM145328. T.W. was supported by the National Institute of Neurological Disorders and Stroke under award number F31NS131037 and the predoctoral Training Program in Molecular and Cellular Biology at UC Davis via the National Institute of General Medical Sciences T32 training grant GM007377. R.A. was supported by an overseas research fellowship from the Japan Society for the Promotion of Science. The content is solely the responsibility of the authors and does not necessarily represent the views of the funding agencies.

Theresa Wechsler and Ryuta Asada contributed equally.

Data Availability Statement

Data sharing are not applicable to this article as no new data were created or analyzed in this study.

References

  1. Adivarahan, S. , Livingston N., Nicholson B., et al. 2018. "Spatial Organization of Single mRNPs at Different Stages of the Gene Expression Pathway." Molecular Cell 72, no. 4: 727–738.e5. 10.1016/j.molcel.2018年10月01日0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aguilera, P. , and Aguilera A.. 2025. "R‐Loop Homeostasis in Genome Dynamics, Gene Expression and Development." Current Opinion in Genetics & Development 92: 102325. 10.1016/j.gde.2025.102325. [DOI] [PubMed] [Google Scholar]
  3. Aibara, S. , Gordon J. M. B., Riesterer A. S., McLaughlin S. H., and Stewart M.. 2017. "Structural Basis for the Dimerization of Nab2 Generated by RNA Binding Provides Insight Into Its Contribution to Both Poly(A) Tail Length Determination and Transcript Compaction in Saccharomyces cerevisiae ." Nucleic Acids Research 45, no. 3: 1529–1538. 10.1093/nar/gkw1224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Akef, A. , Zhang H., and Masuda S.. 2013. "Trafficking of mRNAs Containing ALREX‐Promoting Elements Through Nuclear Speckles." Nucleus 4, no. 4: 326–340. 10.4161/nucl.26052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aksenova, V. , Smith A., Lee H., et al. 2020. "Nucleoporin TPR Is an Integral Component of the TREX‐2 mRNA Export Pathway." Nature Communications 11, no. 1: 4577. 10.1038/s41467-020-18266-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Alberti, S. , and Hyman A. A.. 2021. "Biomolecular Condensates at the Nexus of Cellular Stress, Protein Aggregation Disease and Ageing." Nature Reviews Molecular Cell Biology 22, no. 3: 196–213. 10.1038/s41580-020-00326-6. [DOI] [PubMed] [Google Scholar]
  7. Alexandrov, A. , Colognori D., Shu M.‐D., and Steitz J. A.. 2012. "Human Spliceosomal Protein CWC22 Plays a Role in Coupling Splicing to Exon Junction Complex Deposition and Nonsense‐Mediated Decay." Proceedings of the National Academy of Sciences 109, no. 52: 21313–21318. 10.1073/pnas.1219725110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Andersen, C. B. F. , Ballut L., Johansen J. S., et al. 2006. "Structure of the Exon Junction Core Complex With a Trapped DEAD‐Box ATPase Bound to RNA." Science 313, no. 5795: 1968–1972. 10.1126/science.1131981. [DOI] [PubMed] [Google Scholar]
  9. Arney, J. W. , Laederach A., and Weeks K. M.. 2024. "Visualizing RNA Structure Ensembles by Single‐Molecule Correlated Chemical Probing." Current Opinion in Structural Biology 88: 102877. 10.1016/j.sbi.2024.102877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Asada, R. , Dominguez A., and Montpetit B.. 2023. "Single‐Molecule Quantitation of RNA‐Binding Protein Occupancy and Stoichiometry Defines a Role for Yra1 (Aly/REF) in Nuclear mRNP Organization." Cell Reports 42, no. 11: 113415. 10.1016/j.celrep.2023.113415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ashkenazy‐Titelman, A. , Atrash M. K., Boocholez A., Kinor N., and Shav‐Tal Y.. 2022. "RNA Export Through the Nuclear Pore Complex Is Directional." Nature Communications 13, no. 1: 5881. 10.1038/s41467-022-33572-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ashkenazy‐Titelman, A. , Shav‐Tal Y., and Kehlenbach R. H.. 2020. "Into the Basket and Beyond: The Journey of mRNA Through the Nuclear Pore Complex." Biochemical Journal 477, no. 1: 23–44. 10.1042/BCJ20190132. [DOI] [PubMed] [Google Scholar]
  13. Baejen, C. , Torkler P., Gressel S., Essig K., Söding J., and Cramer P.. 2014. "Transcriptome Maps of mRNP Biogenesis Factors Define Pre‐mRNA Recognition." Molecular Cell 55, no. 5: 745–757. 10.1016/j.molcel.201408005. [DOI] [PubMed] [Google Scholar]
  14. Baltz, A. G. , Munschauer M., Schwanhäusser B., et al. 2012. "The mRNA‐Bound Proteome and Its Global Occupancy Profile on Protein‐Coding Transcripts." Molecular Cell 46, no. 5: 674–690. 10.1016/j.molcel.2012年05月02日1. [DOI] [PubMed] [Google Scholar]
  15. Barbosa, I. , Haque N., Fiorini F., et al. 2012. "Human CWC22 Escorts the Helicase eIF4AIII to Spliceosomes and Promotes Exon Junction Complex Assembly." Nature Structural & Molecular Biology 19, no. 10: 983–990. 10.1038/nsmb.2380. [DOI] [PubMed] [Google Scholar]
  16. Batisse, J. , Batisse C., Budd A., Böttcher B., and Hurt E.. 2009. "Purification of Nuclear Poly(A)‐Binding Protein Nab2 Reveals Association With the Yeast Transcriptome and a Messenger Ribonucleoprotein Core Structure." Journal of Biological Chemistry 284, no. 50: 34911–34917. 10.1074/jbc.M109.062034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bear, D. G. , Fomproix N., Soop T., Björkroth B., Masich S., and Daneholt B.. 2003. "Nuclear Poly(A)‐Binding Protein PABPN1 Is Associated With RNA Polymerase II During Transcription and Accompanies the Released Transcript to the Nuclear Pore." Experimental Cell Research 286, no. 2: 332–344. 10.1016/S0014-4827(03)00123-X. [DOI] [PubMed] [Google Scholar]
  18. Beckmann, B. M. , Horos R., Fischer B., et al. 2015. "The RNA‐Binding Proteomes From Yeast to Man Harbour Conserved EnigmRBPs." Nature Communications 6: 10127. 10.1038/ncomms10127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Beghѐ, C. , Harpham H., Barberic Y., and Gromak N.. 2025. "R‐Loops in Neurodegeneration." Current Opinion in Genetics & Development 92: 102345. 10.1016/j.gde.2025.102345. [DOI] [PubMed] [Google Scholar]
  20. Ben‐Yishay, R. , Mor A., Shraga A., et al. 2019. "Imaging Within Single NPCs Reveals NXF1's Role in mRNA Export on the Cytoplasmic Side of the Pore." Journal of Cell Biology 218, no. 9: 2962–2981. 10.1083/jcb.201901127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bensidoun, P. , Zenklusen D., and Oeffinger M.. 2021. "Choosing the Right Exit: How Functional Plasticity of the Nuclear Pore Drives Selective and Efficient mRNA Export." Wiley Interdisciplinary Reviews: RNA 12, no. 6: e1660. 10.1002/wrna.1660. [DOI] [PubMed] [Google Scholar]
  22. Bensidoun, P. , Reiter T., Montpetit B., Zenklusen D., and Oeffinger M.. 2022. "Nuclear mRNA Metabolism Drives Selective Basket Assembly on a Subset of Nuclear Pore Complexes in Budding Yeast." Molecular Cell 82, no. 20: 3856–3871.e6. 10.1016/j.molcel.2022年09月01日9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Bhandari, J. , Guillén‐Mendoza C., Banks K., et al. 2024. "The Molecular Chaperone ALYREF Promotes R‐Loop Resolution and Maintains Genome Stability." Journal of Biological Chemistry 300, no. 12: 107996. 10.1016/j.jbc.2024.107996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Björk, P. , and Wieslander L.. 2017. "Integration of mRNP Formation and Export." Cellular and Molecular Life Sciences: CMLS 74, no. 16: 2875–2897. 10.1007/s00018-017-2503-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Bonneau, F. , Basquin J., Steigenberger B., Schäfer T., Schäfer I. B., and Conti E.. 2023. "Nuclear mRNPs Are Compact Particles Packaged With a Network of Proteins Promoting RNA–RNA Interactions." Genes & Development 37, no. 11–12: 505–517. 10.1101/gad.350630.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Bono, F. , Ebert J., Lorentzen E., and Conti E.. 2006. "The Crystal Structure of the Exon Junction Complex Reveals How It Maintains a Stable Grip on mRNA." Cell 126, no. 4: 713–725. 10.1016/j.cell.200608006. [DOI] [PubMed] [Google Scholar]
  27. Boo, S. H. , and Kim Y. K.. 2020. "The Emerging Role of RNA Modifications in the Regulation of mRNA Stability." Experimental & Molecular Medicine 52, no. 3: 400–408. 10.1038/s12276-020-0407-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Boreikaitė, V. , and Passmore L. A.. 2023. "3′‐End Processing of Eukaryotic mRNA: Machinery, Regulation, and Impact on Gene Expression." Annual Review of Biochemistry 92: 199–225. 10.1146/annurev-biochem-052521-012445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Boyne, J. R. , Colgan K. J., and Whitehouse A.. 2008. "Recruitment of the Complete hTREX Complex Is Required for Kaposi's Sarcoma–Associated Herpesvirus Intronless mRNA Nuclear Export and Virus Replication." PLoS Pathogens 4, no. 10: e1000194. 10.1371/journal.ppat.1000194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Brody, Y. , Neufeld N., Bieberstein N., et al. 2011. "The In Vivo Kinetics of RNA Polymerase II Elongation During co‐Transcriptional Splicing." PLoS Biology 9, no. 1: e1000573. 10.1371/journal.pbio.1000573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Brune, C. , Munchel S. E., Fischer N., Podtelejnikov A. V., and Weis K.. 2005. "Yeast Poly(A)‐Binding Protein Pab1 Shuttles Between the Nucleus and the Cytoplasm and Functions in mRNA Export." RNA 11, no. 4: 517–531. 10.1261/rna.7291205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Bubenik, J. L. , Hale M., McConnell O., et al. 2021. "RNA Structure Probing to Characterize RNA–Protein Interactions on Low Abundance Pre‐mRNA in Living Cells." RNA 27, no. 3: 343–358. 10.1261/rna.077263.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Cao, X. , Zhang Y., Ding Y., and Wan Y.. 2024. "Identification of RNA Structures and Their Roles in RNA Functions." Nature Reviews Molecular Cell Biology 25, no. 10: 784–801. 10.1038/s41580-024-00748-6. [DOI] [PubMed] [Google Scholar]
  34. Carmody, S. R. , Tran E. J., and Apponi L. H.. 2010. "The Mitogen‐Activated Protein Kinase Slt2 Regulates Nuclear Retention of Non‐Heat Shock mRNAs During Heat Shock‐Induced Stress." Molecular and Cellular Biology 30, no. 21: 5168–5179. 10.1128/MCB.00735-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Carrocci, T. J. , and Neugebauer K. M.. 2024. "Emerging and Re‐Emerging Themes in Co‐Transcriptional Pre‐mRNA Splicing." Molecular Cell 84, no. 19: 3656–3666. 10.1016/j.molcel.2024年08月03日6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Castello, A. , Fischer B., Eichelbaum K., et al. 2012. "Insights Into RNA Biology From an Atlas of Mammalian mRNA‐Binding Proteins." Cell 149, no. 6: 1393–1406. 10.1016/j.cell.2012年04月03日1. [DOI] [PubMed] [Google Scholar]
  37. Chanarat, S. , Seizl M., and Sträßer K.. 2011. "The Prp19 Complex Is a Novel Transcription Elongation Factor Required for TREX Occupancy at Transcribed Genes." Genes & Development 25, no. 11: 1147–1158. 10.1101/gad.623411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chang, C. , Hautbergue G. M., Walsh M. J., et al. 2013. "Chtop Is a Component of the Dynamic TREX mRNA Export Complex." EMBO Journal 32, no. 3: 473–486. 10.1038/emboj.2012.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chen, I.‐H. B. , Li L., Silva L., and Sandri‐Goldin R. M.. 2005. "ICP27 Recruits Aly/REF but Not TAP/NXF1 to Herpes Simplex Virus Type 1 Transcription Sites Although TAP/NXF1 Is Required for ICP27 Export." Journal of Virology 79, no. 7: 3949–3961. 10.1128/jvi.79.7.3949-3961.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Chen, I.‐H. B. , Sciabica K. S., and Sandri‐Goldin R. M.. 2002. "ICP27 Interacts With the RNA Export Factor Aly/REF to Direct Herpes Simplex Virus Type 1 Intronless mRNAs to the TAP Export Pathway." Journal of Virology 76, no. 24: 12877–12889. 10.1128/jvi.76.24.12877-12889.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chen, S. , Wang R., Zheng D., et al. 2019. "The mRNA Export Receptor NXF1 Coordinates Transcriptional Dynamics, Alternative Polyadenylation, and mRNA Export." Molecular Cell 74, no. 1: 118–131.e7. 10.1016/j.molcel.2019年01月02日6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cheng, H. , Dufu K., Lee C.‐S., Hsu J. L., Dias A., and Reed R.. 2006. "Human mRNA Export Machinery Recruited to the 5′ End of mRNA." Cell 127, no. 7: 1389–1400. 10.1016/j.cell.2006年10月04日4. [DOI] [PubMed] [Google Scholar]
  43. Choi, Y. , Um B., Na Y., Kim J., Kim J.‐S., and Kim V. N.. 2024. "Time‐Resolved Profiling of RNA Binding Proteins Throughout the mRNA Life Cycle." Molecular Cell 84, no. 9: 1764–1782.e10. 10.1016/j.molcel.2024年03月01日2. [DOI] [PubMed] [Google Scholar]
  44. Chong, P. A. , Vernon R. M., and Forman‐Kay J. D.. 2018. "RGG/RG Motif Regions in RNA Binding and Phase Separation." Journal of Molecular Biology 430, no. 23: 4650–4665. 10.1016/j.jmb.2018年06月01日4. [DOI] [PubMed] [Google Scholar]
  45. Choquet, K. , Patop I. L., and Churchman L. S.. 2025. "The Regulation and Function of Post‐Transcriptional RNA Splicing." Nature Reviews. Genetics 26: 378–394. 10.1038/s41576-025-00836-z. [DOI] [PubMed] [Google Scholar]
  46. Clarke, B. P. , Angelos A. E., Mei M., Hill P. S., Xie Y., and Ren Y.. 2024. "Cryo‐EM Structure of the CBC‐ALYREF Complex." eLife 12: RP91432. 10.7554/eLife.91432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Clarke, B. P. , Gao S., Mei M., et al. 2025. "Structural Mechanism of DDX39B Regulation by Human TREX‐2 and a Related Complex in mRNP Remodeling." Nature Communications 16, no. 1: 5471. 10.1038/s41467-025-60547-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Cohen, N. , Sharma M., Kentsis A., Perez J. M., Strudwick S., and Borden K. L. B.. 2001. "PML RING Suppresses Oncogenic Transformation by Reducing the Affinity of eIF4E for mRNA." EMBO Journal 20, no. 16: 4547–4559. 10.1093/emboj/20.16.4547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Culjkovic, B. , Topisirovic I., Skrabanek L., Ruiz‐Gutierrez M., and Borden K. L. B.. 2005. "eIF4E Promotes Nuclear Export of Cyclin D1 mRNAs via an Element in the 3′UTR." Journal of Cell Biology 169, no. 2: 245–256. 10.1083/jcb.200501019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Culjkovic, B. , Topisirovic I., Skrabanek L., Ruiz‐Gutierrez M., and Borden K. L. B.. 2006. "eIF4E Is a Central Node of an RNA Regulon That Governs Cellular Proliferation." Journal of Cell Biology 175, no. 3: 415–426. 10.1083/jcb.200607020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. De Conti, L. , Baralle M., and Buratti E.. 2017. "Neurodegeneration and RNA‐Binding Proteins." Wiley Interdisciplinary Reviews: RNA 8, no. 2: e1394. 10.1002/wrna.1394. [DOI] [PubMed] [Google Scholar]
  52. Dermody, J. L. , Dreyfuss J. M., Villén J., et al. 2008. "Unphosphorylated SR‐Like Protein Npl3 Stimulates RNA Polymerase II Elongation." PLoS One 3, no. 9: e3273. 10.1371/journal.pone.0003273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Derrer, C. P. , Mancini R., Vallotton P., Huet S., Weis K., and Dultz E.. 2019. "The RNA Export Factor Mex67 Functions as a Mobile Nucleoporin." Journal of Cell Biology 218, no. 12: 3967–3976. 10.1083/jcb.201909028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Dias, A. P. , Dufu K., Lei H., and Reed R.. 2010. "A Role for TREX Components in the Release of Spliced mRNA From Nuclear Speckle Domains." Nature Communications 1, no. 1: 97. 10.1038/ncomms1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dufu, K. , Livingstone M. J., Seebacher J., Gygi S. P., Wilson S. A., and Reed R.. 2010. "ATP Is Required for Interactions Between UAP56 and Two Conserved mRNA Export Proteins, Aly and CIP29, to Assemble the TREX Complex." Genes & Development 24, no. 18: 2043–2053. 10.1101/gad.1898610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ellisdon, A. M. , Dimitrova L., Hurt E., and Stewart M.. 2012. "Structural Basis for the Assembly and Nucleic Acid Binding of the TREX‐2 Transcription‐Export Complex." Nature Structural & Molecular Biology 19, no. 3: 328–336. 10.1038/nsmb.2235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Faber, G. P. , Nadav‐Eliyahu S., and Shav‐Tal Y.. 2022. "Nuclear Speckles – A Driving Force in Gene Expression." Journal of Cell Science 135, no. 13: jcs259594. 10.1242/jcs.259594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Faraway, R. , Heaven N. C., Digby H., et al. 2023. "Mutual Homeostasis of Charged Proteins." bioRxiv. 10.1101/2023.08.21.554177. [DOI]
  59. Fasken, M. B. , Stewart M., and Corbett A. H.. 2008. "Functional Significance of the Interaction Between the mRNA‐Binding Protein, Nab2, and the Nuclear Pore‐Associated Protein, Mlp1, in mRNA Export*." Journal of Biological Chemistry 283, no. 40: 27130–27143. 10.1074/jbc.M803649200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Fischer, T. , Sträßer K., Rácz A., et al. 2002. "The mRNA Export Machinery Requires the Novel Sac3p–Thp1p Complex to Dock at the Nucleoplasmic Entrance of the Nuclear Pores." EMBO Journal 21, no. 21: 5843–5852. 10.1093/emboj/cdf590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Folco, E. G. , Lee C.‐S., Dufu K., Yamazaki T., and Reed R.. 2012. "The Proteins PDIP3 and ZC11A Associate With the Human TREX Complex in an ATP‐Dependent Manner and Function in mRNA Export." PLoS One 7, no. 8: e43804. 10.1371/journal.pone.0043804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Fradera‐Sola, A. , Nischwitz E., Bayer M. E., Luck K., and Butter F.. 2023. "RNA‐Dependent Interactome Allows Network‐Based Assignment of RNA‐Binding Protein Function." Nucleic Acids Research 51, no. 10: 5162–5176. 10.1093/nar/gkad245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Galganski, L. , Urbanek M. O., and Krzyzosiak W. J.. 2017. "Nuclear Speckles: Molecular Organization, Biological Function and Role in Disease." Nucleic Acids Research 45, no. 18: 10350–10368. 10.1093/nar/gkx759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. García‐Muse, T. , and Aguilera A.. 2019. "R Loops: From Physiological to Pathological Roles." Cell 179, no. 3: 604–618. 10.1016/j.cell.2019年08月05日5. [DOI] [PubMed] [Google Scholar]
  65. Gebauer, F. , Schwarzl T., Valcárcel J., and Hentze M. W.. 2021. "RNA‐Binding Proteins in Human Genetic Disease." Nature Reviews Genetics 22, no. 3: 185–198. 10.1038/s41576-020-00302-y. [DOI] [PubMed] [Google Scholar]
  66. Gilbert, W. , and Guthrie C.. 2004. "The Glc7p Nuclear Phosphatase Promotes mRNA Export by Facilitating Association of Mex67p With mRNA." Molecular Cell 13, no. 2: 201–212. 10.1016/S1097-2765(04)00030-9. [DOI] [PubMed] [Google Scholar]
  67. Gilbert, W. V. , and Nachtergaele S.. 2023. "mRNA Regulation by RNA Modifications." Annual Review of Biochemistry 92: 175–198. 10.1146/annurev-biochem-052521-035949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Gómez‐González, B. , García‐Rubio M., Bermejo R., et al. 2011. "Genome‐Wide Function of THO/TREX in Active Genes Prevents R‐Loop‐Dependent Replication Obstacles." EMBO Journal 30, no. 15: 3106–3119. 10.1038/emboj.2011.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. González, C. I. , Ruiz‐Echevarría M. J., Vasudevan S., Henry M. F., and Peltz S. W.. 2000. "The Yeast hnRNP‐Like Protein Hrp1/Nab4 Marks a Transcript for Nonsense‐Mediated mRNA Decay." Molecular Cell 5, no. 3: 489–499. 10.1016/s1097-2765(00)80443-8. [DOI] [PubMed] [Google Scholar]
  70. Goswami, B. , Nag S., and Ray P. S.. 2024. "Fates and Functions of RNA‐Binding Proteins under Stress." WIREs RNA 15, no. 1: e1825. 10.1002/wrna.1825. [DOI] [PubMed] [Google Scholar]
  71. Green, D. M. , Johnson C. P., Hagan H., and Corbett A. H.. 2003. "The C‐Terminal Domain of Myosin‐Like Protein 1 (Mlp1p) is a Docking Site for Heterogeneous Nuclear Ribonucleoproteins That Are Required for mRNA Export." Proceedings of the National Academy of Sciences 100, no. 3: 1010–1015. 10.1073/pnas.0336594100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Green, D. M. , Marfatia K. A., Crafton E. B., Zhang X., Cheng X., and Corbett A. H.. 2002. "Nab2p Is Required for Poly(A) RNA Export in Saccharomyces cerevisiae and Is Regulated by Arginine Methylation via Hmt1p*." Journal of Biological Chemistry 277, no. 10: 7752–7760. 10.1074/jbc.M110053200. [DOI] [PubMed] [Google Scholar]
  73. Gromadzka, A. M. , Steckelberg A.‐L., Singh K. K., Hofmann K., and Gehring N. H.. 2016. "A Short Conserved Motif in ALYREF Directs Cap‐ and EJC‐Dependent Assembly of Export Complexes on Spliced mRNAs." Nucleic Acids Research 44, no. 5: 2348–2361. 10.1093/nar/gkw009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Grünwald, D. , and Singer R. H.. 2010. "In Vivo Imaging of Labelled Endogenous β‐Actin mRNA During Nucleocytoplasmic Transport." Nature 467, no. 7315: 604–607. 10.1038/nature09438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Guha, S. , and Bhaumik S. R.. 2021. "Viral Regulation of mRNA Export With Potentials for Targeted Therapy." Biochimica et Biophysica Acta 1864, no. 1: 194655. 10.1016/j.bbagrm.2020.194655. [DOI] [PubMed] [Google Scholar]
  76. Gupta, A. , Kumar A., Singh N., et al. 2023. "The Saccharomyces cerevisiae SR Protein Npl3 Interacts With Hyperphosphorylated CTD of RNA Polymerase II." International Journal of Biological Macromolecules 253: 127541. 10.1016/j.ijbiomac.2023.127541. [DOI] [PubMed] [Google Scholar]
  77. Gwizdek, C. , Iglesias N., Rodriguez M. S., et al. 2006. "Ubiquitin‐Associated Domain of Mex67 Synchronizes Recruitment of the mRNA Export Machinery With Transcription." Proceedings of the National Academy of Sciences of the United States of America 103, no. 44: 16376–16381. 10.1073/pnas.0607941103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Ha, T. , Kaiser C., Myong S., Wu B., and Xiao J.. 2022. "Next Generation Single‐Molecule Techniques: Imaging, Labeling, and Manipulation In Vitro and In Cellulo." Molecular Cell 82, no. 2: 304–314. 10.1016/j.molcel.2021年12月01日9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Hackmann, A. , Wu H., Schneider U.‐M., Meyer K., Jung K., and Krebber H.. 2014. "Quality Control of Spliced mRNAs Requires the Shuttling SR Proteins Gbp2 and Hrb1." Nature Communications 5: 3123. 10.1038/ncomms4123. [DOI] [PubMed] [Google Scholar]
  80. Hargous, Y. , Hautbergue G. M., Tintaru A. M., et al. 2006. "Molecular Basis of RNA Recognition and TAP Binding by the SR Proteins SRp20 and 9G8." EMBO Journal 25, no. 21: 5126–5137. 10.1038/sj.emboj.7601385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Harlen, K. M. , and Churchman L. S.. 2017. "The Code and Beyond: Transcription Regulation by the RNA Polymerase II Carboxy‐Terminal Domain." Nature Reviews Molecular Cell Biology 18, no. 4: 263–273. 10.1038/nrm.2017.10. [DOI] [PubMed] [Google Scholar]
  82. Hasenson, S. E. , and Shav‐Tal Y.. 2020. "Speculating on the Roles of Nuclear Speckles: How RNA‐Protein Nuclear Assemblies Affect Gene Expression." BioEssays 42, no. 10: 2000104. 10.1002/bies.202000104. [DOI] [PubMed] [Google Scholar]
  83. Hautbergue, G. M. , Hung M.‐L., Walsh M. J., et al. 2009. "UIF, a New mRNA Export Adaptor That Works Together With REF/ALY, Requires FACT for Recruitment to mRNA." Current Biology 19, no. 22: 1918–1924. 10.1016/j.cub.2009年09月04日1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Heinrich, S. , Hondele M., Marchand D., et al. 2024. "Glucose Stress Causes mRNA Retention in Nuclear Nab2 Condensates." Cell Reports 43, no. 1: 113593. 10.1016/j.celrep.2023.113593. [DOI] [PubMed] [Google Scholar]
  85. Henke‐Schulz, L. , Minocha R., Maier N. H., and Sträßer K.. 2024. "The Prp19C/NTC Subunit Syf2 and the Prp19C/NTC‐Associated Protein Cwc15 Function in TREX Occupancy and Transcription Elongation." RNA 30, no. 7: 854–865. 10.1261/rna.079944.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Hentze, M. W. , Castello A., Schwarzl T., and Preiss T.. 2018. "A Brave New World of RNA‐Binding Proteins." Nature Reviews Molecular Cell Biology 19, no. 5: 327–341. 10.1038/nrm.2017.130. [DOI] [PubMed] [Google Scholar]
  87. Hochberg‐Laufer, H. , Neufeld N., Brody Y., Nadav‐Eliyahu S., Ben‐Yishay R., and Shav‐Tal Y.. 2019. "Availability of Splicing Factors in the Nucleoplasm Can Regulate the Release of mRNA From the Gene After Transcription." PLoS Genetics 15, no. 11: e1008459. 10.1371/journal.pgen.1008459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Hohmann, U. , Graf M., Schellhaas U., et al. 2024. "A Molecular Switch Orchestrates the Nuclear Export of Human Messenger RNA." bioRxiv. 10.1101/2024.03.24.586400. [DOI]
  89. Howard, J. M. , and Sanford J. R.. 2015. "The RNAissance Family: SR Proteins as Multifaceted Regulators of Gene Expression." Wiley Interdisciplinary Reviews: RNA 6, no. 1: 93–110. 10.1002/wrna.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hsin, J.‐P. , and Manley J. L.. 2012. "The RNA Polymerase II CTD Coordinates Transcription and RNA Processing." Genes & Development 26, no. 19: 2119–2137. 10.1101/gad.200303.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Huertas, P. , and Aguilera A.. 2003. "Cotranscriptionally Formed DNA:RNA Hybrids Mediate Transcription Elongation Impairment and Transcription‐Associated Recombination." Molecular Cell 12, no. 3: 711–721. 10.1016/j.molcel.2003年08月01日0. [DOI] [PubMed] [Google Scholar]
  92. Hug, N. , Longman D., and Cáceres J. F.. 2016. "Mechanism and Regulation of the Nonsense‐Mediated Decay Pathway." Nucleic Acids Research 44, no. 4: 1483–1495. 10.1093/nar/gkw010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Hurowitz, E. H. , and Brown P. O.. 2003. "Genome‐Wide Analysis of mRNA Lengths in Saccharomyces cerevisiae ." Genome Biology 5, no. 1: R2. 10.1186/gb-2003年5月1日-r2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Hurt, E. , Luo M.‐J., Röther S., Reed R., and Strässer K.. 2004. "Cotranscriptional Recruitment of the Serine‐Arginine‐Rich (SR)‐Like Proteins Gbp2 and Hrb1 to Nascent mRNA via the TREX Complex." Proceedings of the National Academy of Sciences of the United States of America 101, no. 7: 1858–1862. 10.1073/pnas.0308663100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Iborra, F. J. , Jackson D. A., and Cook P. R.. 2001. "Coupled Transcription and Translation Within Nuclei of Mammalian Cells." Science 293, no. 5532: 1139–1142. 10.1126/science.1061216. [DOI] [PubMed] [Google Scholar]
  96. Ietswaart, R. , Smalec B. M., Xu A., et al. 2024. "Genome‐Wide Quantification of RNA Flow Across Subcellular Compartments Reveals Determinants of the Mammalian Transcript Life Cycle." Molecular Cell 84, no. 14: 2765–2784.e16. 10.1016/j.molcel.202406008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Iglesias, N. , Tutucci E., Gwizdek C., et al. 2010. "Ubiquitin‐Mediated mRNP Dynamics and Surveillance Prior to Budding Yeast mRNA Export." Genes & Development 24, no. 17: 1927–1938. 10.1101/gad.583310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Infantino, V. , and Stutz F.. 2020. "The Functional Complexity of the RNA‐Binding Protein Yra1: mRNA Biogenesis, Genome Stability and DSB Repair." Current Genetics 66: 63–71. 10.1007/s00294-019-01011-8. [DOI] [PubMed] [Google Scholar]
  99. Jackson, B. R. , Boyne J. R., Noerenberg M., et al. 2011. "An Interaction Between KSHV ORF57 and UIF Provides mRNA‐Adaptor Redundancy in Herpesvirus Intronless mRNA Export." PLoS Pathogens 7, no. 7: e1002138. 10.1371/journal.ppat.1002138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Janicki, S. M. , Tsukamoto T., Salghetti S. E., et al. 2004. "From Silencing to Gene Expression: Real‐Time Analysis in Single Cells." Cell 116, no. 5: 683–698. 10.1016/S0092-8674(04)00171-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Jensen, T. H. , Dower K., Libri D., and Rosbash M.. 2003. "Early Formation of mRNP: License for Export or Quality Control?" Molecular Cell 11, no. 5: 1129–1138. 10.1016/S1097-2765(03)00191-6. [DOI] [PubMed] [Google Scholar]
  102. Jeong, S. 2017. "SR Proteins: Binders, Regulators, and Connectors of RNA." Molecules and Cells 40, no. 1: 1–9. 10.14348/molcells.2017.2319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Jimeno, S. , Luna R., and García‐Rubio M.. 2006. "Tho1, a Novel hnRNP, and Sub2 Provide Alternative Pathways for mRNP Biogenesis in Yeast THO Mutants." Molecular and Cellular Biology 26, no. 12: 4387–4398. 10.1128/MCB.00234-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Katahira, J. , Inoue H., Hurt E., and Yoneda Y.. 2009. "Adaptor Aly and Co‐Adaptor Thoc5 Function in the Tap‐p15‐Mediated Nuclear Export of HSP70 mRNA." EMBO Journal 28, no. 5: 556–567. 10.1038/emboj.2009.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Katahira, J. , Ohmae T., Yasugi M., et al. 2023. "Nsp14 of SARS‐CoV‐2 Inhibits mRNA Processing and Nuclear Export by Targeting the Nuclear Cap‐Binding Complex." Nucleic Acids Research 51, no. 14: 7602–7618. 10.1093/nar/gkad483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Katahira, J. , Sträßer K., Podtelejnikov A., Mann M., Jung J. U., and Hurt E.. 1999. "The Mex67p‐Mediated Nuclear mRNA Export Pathway Is Conserved From Yeast to Human." EMBO Journal 18, no. 9: 2593–2609. 10.1093/emboj/18.9.2593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Keil, P. , Wulf A., Kachariya N., et al. 2023. "Npl3 Functions in mRNP Assembly by Recruitment of mRNP Components to the Transcription Site and Their Transfer Onto the mRNA." Nucleic Acids Research 51, no. 2: 831–851. 10.1093/nar/gkac1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Kelly, S. M. , Leung S. W., Pak C., Banerjee A., Moberg K. H., and Corbett A. H.. 2014. "A Conserved Role for the Zinc Finger Polyadenosine RNA Binding Protein, ZC3H14, in Control of Poly(A) Tail Length." RNA 20, no. 5: 681–688. 10.1261/rna.043984.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Kern, C. , Radon C., Wende W., Leitner A., and Sträßer K.. 2023. "Cross‐Linking Mass Spectrometric Analysis of the Endogenous TREX Complex From Saccharomyces cerevisiae ." RNA 29, no. 12: 1870–1880. 10.1261/rna.079758.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Kessler, M. M. , Henry M. F., Shen E., et al. 1997. "Hrp1, a Sequence‐Specific RNA‐Binding Protein That Shuttles Between the Nucleus and the Cytoplasm, Is Required for mRNA 3′‐End Formation in Yeast." Genes & Development 11, no. 19: 2545–2556. 10.1101/gad.11.19.2545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Kessler, S. H. , and Sachs A. B.. 1998. "RNA Recognition Motif 2 of Yeast Pab1p Is Required for Its Functional Interaction With Eukaryotic Translation Initiation Factor 4G." Molecular and Cellular Biology 18, no. 1: 51–57. 10.1128/MCB.18.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Khong, A. , and Parker R.. 2018. "mRNP Architecture in Translating and Stress Conditions Reveals an Ordered Pathway of mRNP Compaction." Journal of Cell Biology 217, no. 12: 4124–4140. 10.1083/jcb.201806183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Khong, A. , and Parker R.. 2020. "The Landscape of Eukaryotic mRNPs." RNA 26, no. 3: 229–239. 10.1261/rna.073601.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Klama, S. , Hirsch A. G., Schneider U. M., Zander G., Seel A., and Krebber H.. 2022. "A Guard Protein Mediated Quality Control Mechanism Monitors 5′‐Capping of Pre‐mRNAs." Nucleic Acids Research 50, no. 19: 11301–11314. 10.1093/nar/gkac952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Koffa, M. D. , Clements J. B., Izaurralde E., et al. 2001. "Herpes Simplex Virus ICP27 Protein Provides Viral mRNAs With Access to the Cellular mRNA Export Pathway." EMBO Journal 20, no. 20: 5769–5778. 10.1093/emboj/20.20.5769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Köhler, A. , and Hurt E.. 2007. "Exporting RNA From the Nucleus to the Cytoplasm." Nature Reviews Molecular Cell Biology 8, no. 10: 761–773. 10.1038/nrm2255. [DOI] [PubMed] [Google Scholar]
  117. Kress, T. L. , Krogan N. J., and Guthrie C.. 2008. "A Single SR‐Like Protein, Npl3, Promotes Pre‐mRNA Splicing in Budding Yeast." Molecular Cell 32, no. 5: 727–734. 10.1016/j.molcel.2008年11月01日3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Kumar, J. , Lackey L., Waldern J. M., et al. 2022. "Quantitative Prediction of Variant Effects on Alternative Splicing in MAPT Using Endogenous Pre‐Messenger RNA Structure Probing." eLife 11: e73888. 10.7554/eLife.73888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Kwon, S. C. , Yi H., Eichelbaum K., et al. 2013. "The RNA‐Binding Protein Repertoire of Embryonic Stem Cells." Nature Structural & Molecular Biology 20, no. 9: 1122–1130. 10.1038/nsmb.2638. [DOI] [PubMed] [Google Scholar]
  120. Lai, M.‐C. , and Tarn W.‐Y.. 2004. "Hypophosphorylated ASF/SF2 Binds TAP and Is Present in Messenger Ribonucleoproteins *." Journal of Biological Chemistry 279, no. 30: 31745–31749. 10.1074/jbc.C400173200. [DOI] [PubMed] [Google Scholar]
  121. Lang, V. , Zanchin N. I., Lünsdorf H., Tuite M., and McCarthy J. E.. 1994. "Initiation Factor eIF‐4E of Saccharomyces cerevisiae . Distribution Within the Cell, Binding to mRNA, and Consequences of Its Overproduction." Journal of Biological Chemistry 269, no. 8: 6117–6123. 10.1016/S0021-9258(17)37577-4. [DOI] [PubMed] [Google Scholar]
  122. Lee, E. S. , Wolf E. J., Ihn S. S. J., Smith H. W., Emili A., and Palazzo A. F.. 2020. "TPR Is Required for the Efficient Nuclear Export of mRNAs and lncRNAs From Short and Intron‐Poor Genes." Nucleic Acids Research 48, no. 20: 11645–11663. 10.1093/nar/gkaa919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Lee, S. , Lee Y., Choi Y., et al. 2021. "The SARS‐CoV‐2 RNA Interactome." Molecular Cell 81, no. 13: 2838–2850.e6. 10.1016/j.molcel.2021年04月02日2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Li, J. , Querl L., Coban I., Salinas G., and Krebber H.. 2023. "Surveillance of 3′ mRNA Cleavage During Transcription Termination Requires CF IB/Hrp1." Nucleic Acids Research 51, no. 16: 8758–8773. 10.1093/nar/gkad530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Lischka, P. , Toth Z., Thomas M., Mueller R., and Stamminger T.. 2006. "The UL69 Transactivator Protein of Human Cytomegalovirus Interacts With DEXD/H‐Box RNA Helicase UAP56 to Promote Cytoplasmic Accumulation of Unspliced RNA." Molecular and Cellular Biology 26, no. 5: 1631–1643. 10.1128/MCB.26.5.1631-1643.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Liu, Z. , Liu Q., Yang X., et al. 2021. "In Vivo Nuclear RNA Structurome Reveals RNA‐Structure Regulation of mRNA Processing in Plants." Genome Biology 22, no. 1: 11. 10.1186/s13059-020-02236-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Luna, R. , Gómez‐González B., and Aguilera A.. 2024. "RNA Biogenesis and RNA Metabolism Factors as R‐Loop Suppressors: A Hidden Role in Genome Integrity." Genes & Development 38, no. 11–12: 504–527. 10.1101/gad.351853.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Luna, R. , Rondón A. G., and Aguilera A.. 2012. "New Clues to Understand the Role of THO and Other Functionally Related Factors in mRNP Biogenesis." Biochimica et Biophysica Acta 1819, no. 6: 514–520. 10.1016/j.bbagrm.2011年11月01日2. [DOI] [PubMed] [Google Scholar]
  129. Luna, R. , Rondón A. G., Pérez‐Calero C., Salas‐Armenteros I., and Aguilera A.. 2019. "The THO Complex as a Paradigm for the Prevention of Cotranscriptional R‐Loops." Cold Spring Harbor Symposia on Quantitative Biology 84: 105–114. 10.1101/sqb.201984039594. [DOI] [PubMed] [Google Scholar]
  130. MacKellar, A. L. , and Greenleaf A. L.. 2011. "Cotranscriptional Association of mRNA Export Factor Yra1 With C‐Terminal Domain of RNA Polymerase II." Journal of Biological Chemistry 286, no. 42: 36385–36395. 10.1074/jbc.M111.268144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Malik, P. , Blackbourn D. J., and Clements J. B.. 2004. "The Evolutionarily Conserved Kaposi's Sarcoma‐Associated Herpesvirus ORF57 Protein Interacts With REF Protein and Acts as an RNA Export Factor*." Journal of Biological Chemistry 279, no. 31: 33001–33011. 10.1074/jbc.M313008200. [DOI] [PubMed] [Google Scholar]
  132. Mars, J.‐C. , Culjkovic‐Kraljacic B., and Borden K. L. B.. 2024. "eIF4E Orchestrates mRNA Processing, RNA Export and Translation to Modify Specific Protein Production." Nucleus 15, no. 1: 2360196. 10.1080/19491034.2024.2360196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Martin, E. W. , and Holehouse A. S.. 2020. "Intrinsically Disordered Protein Regions and Phase Separation: Sequence Determinants of Assembly or Lack Thereof." Emerging Topics in Life Sciences 4, no. 3: 307–329. 10.1042/ETLS20190164. [DOI] [PubMed] [Google Scholar]
  134. Martinez, N. M. , Su A., Burns M. C., et al. 2022. "Pseudouridine Synthases Modify Human Pre‐mRNA Co‐Transcriptionally and Affect Pre‐mRNA Processing." Molecular Cell 82, no. 3: 645–659.e9. 10.1016/j.molcel.2021年12月02日3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Masuda, S. , Das R., Cheng H., Hurt E., Dorman N., and Reed R.. 2005. "Recruitment of the Human TREX Complex to mRNA During Splicing." Genes & Development 19, no. 13: 1512–1517. 10.1101/gad.1302205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Meinel, D. M. , Burkert‐Kautzsch C., Kieser A., et al. 2013. "Recruitment of TREX to the Transcription Machinery by Its Direct Binding to the Phospho‐CTD of RNA Polymerase II." PLoS Genetics 9, no. 11: e1003914. 10.1371/journal.pgen.1003914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Metkar, M. , Ozadam H., Lajoie B. R., et al. 2018. "Higher‐Order Organization Principles of Pre‐Translational mRNPs." Molecular Cell 72, no. 4: 715–726.e3. 10.1016/j.molcel.2018年09月01日2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Mitchell, S. F. , Jain S., She M., and Parker R.. 2013. "Global Analysis of Yeast mRNPs." Nature Structural & Molecular Biology 20, no. 1: 127–133. 10.1038/nsmb.2468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Mor, A. , Suliman S., Ben‐Yishay R., Yunger S., Brody Y., and Shav‐Tal Y.. 2010. "Dynamics of Single mRNP Nucleocytoplasmic Transport and Export Through the Nuclear Pore in Living Cells." Nature Cell Biology 12, no. 6: 543–552. 10.1038/ncb2056. [DOI] [PubMed] [Google Scholar]
  140. Morris, K. J. , and Corbett A. H.. 2018. "The Polyadenosine RNA‐Binding Protein ZC3H14 Interacts With the THO Complex and Coordinately Regulates the Processing of Neuronal Transcripts." Nucleic Acids Research 46, no. 13: 6561–6575. 10.1093/nar/gky446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Moursy, A. , Cléry A., Gerhardy S., et al. 2023. "RNA Recognition by Npl3p Reveals U2 snRNA‐Binding Compatible With a Chaperone Role During Splicing." Nature Communications 14, no. 1: 7166. 10.1038/s41467-023-42962-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Mudiyanselage, S. D. D. , Wulfridge P., and Sarma K.. 2025. "The Paradox of R‐Loops: Guardians of the Genome or Drivers of Disease?" Genome Research 35, no. 9: 1919–1928. 10.1101/gr.278992.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Müller‐McNicoll, M. , Botti V., de Domingues A. M. J., et al. 2016. "SR Proteins Are NXF1 Adaptors That Link Alternative RNA Processing to mRNA Export." Genes & Development 30, no. 5: 553–566. 10.1101/gad.276477.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Mustoe, A. M. , Weidmann C. A., and Weeks K. M.. 2023. "Single‐Molecule Correlated Chemical Probing: A Revolution in RNA Structure Analysis." Accounts of Chemical Research 56, no. 7: 763–775. 10.1021/acs.accounts.2c00782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Oeffinger, M. , Wei K. E., Rogers R., et al. 2007. "Comprehensive Analysis of Diverse Ribonucleoprotein Complexes." Nature Methods 4, no. 11: 951–956. 10.1038/nmeth1101. [DOI] [PubMed] [Google Scholar]
  146. Ote, I. , Lebrun M., Vandevenne P., et al. 2009. "Varicella‐Zoster Virus IE4 Protein Interacts With SR Proteins and Exports mRNAs Through the TAP/NXF1 Pathway." PLoS One 4, no. 11: e7882. 10.1371/journal.pone.0007882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Pacheco‐Fiallos, B. , Vorländer M. K., Riabov‐Bassat D., et al. 2023. "mRNA Recognition and Packaging by the Human Transcription–Export Complex." Nature 616, no. 7958: 828–835. 10.1038/s41586-023-05904-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Peña, A. , Gewartowski K., Mroczek S., et al. 2012. "Architecture and Nucleic Acids Recognition Mechanism of the THO Complex, an mRNP Assembly Factor." EMBO Journal 31, no. 6: 1605–1616. 10.1038/emboj.2012.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Perez‐Perri, J. I. , Rogell B., Schwarzl T., et al. 2018. "Discovery of RNA‐Binding Proteins and Characterization of Their Dynamic Responses by Enhanced RNA Interactome Capture." Nature Communications 9, no. 1: 4408. 10.1038/s41467-018-06557-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Piruat, J. I. , and Aguilera A.. 1998. "A Novel Yeast Gene, THO2, Is Involved in RNA Pol II Transcription and Provides New Evidence for Transcriptional Elongation‐Associated Recombination." EMBO Journal 17, no. 16: 4859–4872. 10.1093/emboj/17.16.4859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Portman, D. S. , O'Connor J. P., and Dreyfuss G.. 1997. "YRA1, an Essential Saccharomyces cerevisiae Gene, Encodes a Novel Nuclear Protein With RNA Annealing Activity." RNA 3, no. 5: 527–537. [PMC free article] [PubMed] [Google Scholar]
  152. Pryor, A. , Tung L., Yang Z., Kapadia F., Chang T., and Johnson L. F.. 2004. "Growth‐Regulated Expression and G0‐Specific Turnover of the mRNA That Encodes URH49, a Mammalian DExH/D Box Protein That Is Highly Related to the mRNA Export Protein UAP56." Nucleic Acids Research 32, no. 6: 1857–1865. 10.1093/nar/gkh347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Pühringer, T. , Hohmann U., Fin L., et al. 2020. "Structure of the Human Core Transcription‐Export Complex Reveals a Hub for Multivalent Interactions." eLife 9: e61503. 10.7554/eLife.61503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Queiroz, R. M. L. , Smith T., Villanueva E., et al. 2019. "Comprehensive Identification of RNA–Protein Interactions in Any Organism Using Orthogonal Organic Phase Separation (OOPS)." Nature Biotechnology 37, no. 2: 169–178. 10.1038/s41587-018-0001-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Ramanathan, A. , Robb G. B., and Chan S.‐H.. 2016. "mRNA Capping: Biological Functions and Applications." Nucleic Acids Research 44, no. 16: 7511–7526. 10.1093/nar/gkw551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Rambout, X. , and Maquat L. E.. 2020. "The Nuclear Cap‐Binding Complex as Choreographer of Gene Transcription and Pre‐mRNA Processing." Genes & Development 34, no. 17: 1113–1127. 10.1101/gad.339986.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Reichel, M. , Liao Y., Rettel M., et al. 2016. "In Planta Determination of the mRNA‐Binding Proteome of Arabidopsis Etiolated Seedlings." Plant Cell 28, no. 10: 2435–2452. 10.1105/tpc.16.00562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Ren, Y. , Schmiege P., and Blobel G.. 2017. "Structural and Biochemical Analyses of the DEAD‐Box ATPase Sub2 in Association With THO or Yra1." eLife 6: e20070. 10.7554/eLife.20070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Rissland, O. S. 2017. "The Organization and Regulation of mRNA–Protein Complexes." Wiley Interdisciplinary Reviews: RNA 8, no. 1: e1369. 10.1002/wrna.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Rodríguez‐Molina, J. B. , and Turtola M.. 2023. "Birth of a Poly(A) Tail: Mechanisms and Control of mRNA Polyadenylation." FEBS Open Bio 13, no. 7: 1140–1153. 10.1002/2211-5463.13528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Rodríguez‐Molina, J. B. , West S., and Passmore L. A.. 2023. "Knowing When to Stop: Transcription Termination on Protein‐Coding Genes by Eukaryotic RNAPII." Molecular Cell 83, no. 3: 404–415. 10.1016/j.molcel.2022年12月02日1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Saavedra, C. , Tung K. S., Amberg D. C., Hopper A. K., and Cole C. N.. 1996. "Regulation of mRNA Export in Response to Stress in Saccharomyces cerevisiae ." Genes & Development 10, no. 13: 1608–1620. 10.1101/gad.10.13.1608. [DOI] [PubMed] [Google Scholar]
  163. Sandhu, R. , Sinha A., and Montpetit B.. 2021. "The SR‐Protein Npl3 Is an Essential Component of the Meiotic Splicing Regulatory Network in Saccharomyces cerevisiae ." Nucleic Acids Research 49, no. 5: 2552–2568. 10.1093/nar/gkab071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Saroufim, M.‐A. , Bensidoun P., Raymond P., et al. 2015. "The Nuclear Basket Mediates Perinuclear mRNA Scanning in Budding Yeast." Journal of Cell Biology 211, no. 6: 1131–1140. 10.1083/jcb.201503070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Schärfen, L. , Vock I. W., Simon M. D., and Neugebauer K. M.. 2025. "Rapid Folding of Nascent RNA Regulates Eukaryotic RNA Biogenesis." Molecular Cell 85, no. 8: 1561–1574.e5. 10.1016/j.molcel.2025年02月02日5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Schlautmann, L. P. , and Gehring N. H.. 2020. "A Day in the Life of the Exon Junction Complex." Biomolecules 10, no. 6: 6. 10.3390/biom10060866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Schuller, S. K. , Schuller J. M., Prabu J. R., et al. 2020. "Structural Insights Into the Nucleic Acid Remodeling Mechanisms of the Yeast THO‐Sub2 Complex." eLife 9: e61467. 10.7554/eLife.61467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Schumann, S. , Baquero‐Perez B., and Whitehouse A.. 2016. "Interactions Between KSHV ORF57 and the Novel Human TREX Proteins, CHTOP and CIP29." Journal of General Virology 97, no. 8: 1904–1910. 10.1099/jgv.0.000503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Sen, R. , Barman P., Kaja A., et al. 2019. "Distinct Functions of the Cap‐Binding Complex in Stimulation of Nuclear mRNA Export." Molecular and Cellular Biology 39, no. 8: e00540‐18. 10.1128/MCB.00540-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Senn, K. A. , and Hoskins A. A.. 2024. "Mechanisms and Regulation of Spliceosome‐Mediated Pre‐mRNA Splicing in Saccharomyces cerevisiae ." Wiley Interdisciplinary Reviews: RNA 15, no. 4: e1866. 10.1002/wrna.1866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Shenasa, H. , and Bentley D. L.. 2023. "Pre‐mRNA Splicing and Its Cotranscriptional Connections." Trends in Genetics 39, no. 9: 672–685. 10.1016/j.tig.202304008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Singh, G. , Kucukural A., Cenik C., et al. 2012. "The Cellular EJC Interactome Reveals Higher‐Order mRNP Structure and an EJC‐SR Protein Nexus." Cell 151, no. 4: 750–764. 10.1016/j.cell.201210007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Singh, G. , Pratt G., Yeo G. W., and Moore M. J.. 2015. "The Clothes Make the mRNA: Past and Present Trends in mRNP Fashion." Annual Review of Biochemistry 84: 325–354. 10.1146/annurev-biochem-080111-092106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Singh, N. , Asalam M., Ansari M. O., Gerasimova N. S., Studitsky V. M., and Akhtar M. S.. 2022. "Transcription by RNA Polymerase II and the CTD‐Chromatin Crosstalk." Biochemical and Biophysical Research Communications 599: 81–86. 10.1016/j.bbrc.2022年02月03日9. [DOI] [PubMed] [Google Scholar]
  175. Skoglund, U. , Andersson K., Björkroth B., Lamb M. M., and Daneholt B.. 1983. "Visualization of the Formation and Transport of a Specific hnRNP Particle." Cell 34, no. 3: 847–855. 10.1016/0092-8674(83)90542-1. [DOI] [PubMed] [Google Scholar]
  176. Skoglund, U. , Andersson K., Strandberg B., and Daneholt B.. 1986. "Three‐Dimensional Structure of a Specific Pre‐Messenger RNP Particle Established by Electron Microscope Tomography." Nature 319, no. 6054: 560–564. 10.1038/319560a0. [DOI] [PubMed] [Google Scholar]
  177. Smith, C. , Lari A., Derrer C. P., et al. 2015. "In Vivo Single‐Particle Imaging of Nuclear mRNA Export in Budding Yeast Demonstrates an Essential Role for Mex67p." Journal of Cell Biology 211, no. 6: 1121–1130. 10.1083/jcb.201503135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Soheilypour, M. , and Mofrad M. R. K.. 2018. "Quality Control of mRNAs at the Entry of the Nuclear Pore: Cooperation in a Complex Molecular System." Nucleus 9, no. 1: 202–211. 10.1080/19491034.2018.1439304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Soto‐Machuca, A. A. , Ortiz G. E., Carbone‐Schellman J., et al. 2025. "Role of Human Herpesvirus Homologs of Infected Cell Protein 27 (ICP27) in the Biogenesis, Processing, and Maturation of mRNAs." MBio 16, no. 4: e00291‐25. 10.1128/mbio.00291-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Steckelberg, A.‐L. , Boehm V., Gromadzka A. M., and Gehring N. H.. 2012. "CWC22 Connects Pre‐mRNA Splicing and Exon Junction Complex Assembly." Cell Reports 2, no. 3: 454–461. 10.1016/j.celrep.2012年08月01日7. [DOI] [PubMed] [Google Scholar]
  181. Stenum, T. S. , Kumar A. D., Sandbaumhüter F. A., et al. 2023. "RNA Interactome Capture in Escherichia coli Globally Identifies RNA‐Binding Proteins." Nucleic Acids Research 51, no. 9: 4572–4587. 10.1093/nar/gkad216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Stewart, M. 2019. "Polyadenylation and Nuclear Export of mRNAs." Journal of Biological Chemistry 294, no. 9: 2977–2987. 10.1074/jbc.REV118.005594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Stötzel, J. , Warwick T., Tirunagari P., Brandes R. P., and Leisegang M. S.. 2025. "The Relevance of RNA–DNA Interactions as Regulators of Physiological Functions." Pflügers Archiv‐European Journal of Physiology 477, no. 7: 889–901. 10.1007/s00424-025-03091-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Strässer, K. , Bassler J., and Hurt E.. 2000. "Binding of the Mex67p/Mtr2p Heterodimer to FXFG, GLFG, and FG Repeat Nucleoporins Is Essential for Nuclear mRNA Export." Journal of Cell Biology 150, no. 4: 695–706. 10.1083/jcb.150.4.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Strässer, K. , and Hurt E.. 2000. "Yra1p, a Conserved Nuclear RNA‐Binding Protein, Interacts Directly With Mex67p and Is Required for mRNA Export." EMBO Journal 19, no. 3: 410–420. 10.1093/emboj/19.3.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Sträßer, K. , Masuda S., Mason P., et al. 2002. "TREX Is a Conserved Complex Coupling Transcription With Messenger RNA Export." Nature 417, no. 6886: 304–308. 10.1038/nature746. [DOI] [PubMed] [Google Scholar]
  187. Street, L. A. , Rothamel K. L., Brannan K. W., et al. 2024. "Large‐Scale Map of RNA‐Binding Protein Interactomes Across the mRNA Life Cycle." Molecular Cell 84, no. 19: 3790–3809.e8. 10.1016/j.molcel.2024年08月03日0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Stutz, F. , Bachi A., Doerks T., et al. 2000. "REF, an Evolutionary Conserved Family of hnRNP‐Like Proteins, Interacts With TAP/Mex67p and Participates in mRNA Nuclear Export." RNA 6, no. 4: 638–650. 10.1017/s1355838200000078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Sun, H. , Li K., Liu C., and Yi C.. 2023. "Regulation and Functions of Non‐m6A mRNA Modifications." Nature Reviews Molecular Cell Biology 24, no. 10: 714–731. 10.1038/s41580-023-00622-x. [DOI] [PubMed] [Google Scholar]
  190. Sun, L. , Fazal F. M., Li P., et al. 2019. "RNA Structure Maps Across Mammalian Cellular Compartments." Nature Structural & Molecular Biology 26, no. 4: 322–330. 10.1038/s41594-019-0200-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Sysoev, V. O. , Fischer B., Frese C. K., et al. 2016. "Global Changes of the RNA‐Bound Proteome During the Maternal‐to‐Zygotic Transition in Drosophila." Nature Communications 7, no. 1: 12128. 10.1038/ncomms12128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Teng, I.‐F. , and Wilson S. A.. 2013. "Mapping Interactions Between mRNA Export Factors in Living Cells." PLoS One 8, no. 6: e67676. 10.1371/journal.pone.0067676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Tintaru, A. M. , Hautbergue G. M., Hounslow A. M., et al. 2007. "Structural and Functional Analysis of RNA and TAP Binding to SF2/ASF." EMBO Reports 8, no. 8: 756–762. 10.1038/sj.embor.7401031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Topisirovic, I. , Siddiqui N., Lapointe V. L., et al. 2009. "Molecular Dissection of the Eukaryotic Initiation Factor 4E (eIF4E) Export‐Competent RNP." EMBO Journal 28, no. 8: 1087–1098. 10.1038/emboj.2009.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Tuck, A. C. , and Tollervey D.. 2013. "A Transcriptome‐Wide Atlas of RNP Composition Reveals Diverse Classes of mRNAs and lncRNAs." Cell 154, no. 5: 996–1009. 10.1016/j.cell.2013年07月04日7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Tudek, A. , Krawczyk P. S., Mroczek S., et al. 2021. "Global View on the Metabolism of RNA Poly(A) Tails in Yeast Saccharomyces cerevisiae ." Nature Communications 12, no. 1: 4951. 10.1038/s41467-021-25251-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Turtola, M. , Manav M. C., Kumar A., et al. 2021. "Three‐Layered Control of mRNA Poly(A) Tail Synthesis in Saccharomyces cerevisiae ." Genes & Development 35, no. 17–18: 1290–1303. 10.1101/gad.348634.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Umlauf, D. , Bonnet J., Waharte F., et al. 2013. "The Human TREX‐2 Complex Is Stably Associated With the Nuclear Pore Basket." Journal of Cell Science 126, no. 12: 2656–2667. 10.1242/jcs.118000. [DOI] [PubMed] [Google Scholar]
  199. Van Nostrand, E. L. , Freese P., Pratt G. A., et al. 2020. "A Large‐Scale Binding and Functional Map of Human RNA‐Binding Proteins." Nature 583, no. 7818: 711–719. 10.1038/s41586-020-2077-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Velázquez‐Cruz, A. , Baños‐Jaime B., Díaz‐Quintana A., De la Rosa M. A., and Díaz‐Moreno I., 2021. "Post‐translational Control of RNA‐Binding Proteins and Disease‐Related Dysregulation." Frontiers in Molecular Biosciences 8. 10.3389/fmolb.2021.658852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Venkat Ramani, M. K. , Yang W., Irani S., and Zhang Y.. 2021. "Simplicity Is the Ultimate Sophistication—Crosstalk of Post‐Translational Modifications on the RNA Polymerase II." Journal of Molecular Biology 433, no. 14: 166912. 10.1016/j.jmb.2021.166912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Viphakone, N. , Cumberbatch M. G., Livingstone M. J., et al. 2015. "Luzp4 Defines a New mRNA Export Pathway in Cancer Cells." Nucleic Acids Research 43, no. 4: 2353–2366. 10.1093/nar/gkv070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Viphakone, N. , Sudbery I., Griffith L., Heath C. G., Sims D., and Wilson S. A.. 2019. "Co‐Transcriptional Loading of RNA Export Factors Shapes the Human Transcriptome." Molecular Cell 75, no. 2: 310–323.e8. 10.1016/j.molcel.2019年04月03日4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Viphakone, N. , Voisinet‐Hakil F., and Minvielle‐Sebastia L.. 2008. "Molecular Dissection of mRNA Poly(A) Tail Length Control in Yeast." Nucleic Acids Research 36, no. 7: 2418–2433. 10.1093/nar/gkn080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Volpon, L. , Culjkovic‐Kraljacic B., Osborne M. J., et al. 2016. "Importin 8 Mediates m7G Cap‐Sensitive Nuclear Import of the Eukaryotic Translation Initiation Factor eIF4E." Proceedings of the National Academy of Sciences 113, no. 19: 5263–5268. 10.1073/pnas.1524291113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Volpon, L. , Culjkovic‐Kraljacic B., Sohn H. S., Blanchet‐Cohen A., Osborne M. J., and Borden K. L. B.. 2017. "A Biochemical Framework for eIF4E‐Dependent mRNA Export and Nuclear Recycling of the Export Machinery." RNA 23, no. 6: 927–937. 10.1261/rna.060137.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Wan, Y. , Qu K., Ouyang Z., et al. 2012. "Genome‐Wide Measurement of RNA Folding Energies." Molecular Cell 48, no. 2: 169–181. 10.1016/j.molcel.201208008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Wang, K. , Wang L., Wang J., Chen S., Shi M., and Cheng H.. 2018. "Intronless mRNAs Transit Through Nuclear Speckles to Gain Export Competence." Journal of Cell Biology 217, no. 11: 3912–3929. 10.1083/jcb.201801184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Wang, X.‐W. , Liu C.‐X., Chen L.‐L., and Zhang Q. C.. 2021. "RNA Structure Probing Uncovers RNA Structure‐Dependent Biological Functions." Nature Chemical Biology 17, no. 7: 755–766. 10.1038/s41589-021-00805-7. [DOI] [PubMed] [Google Scholar]
  210. Wechsler, T. , Asada R., Dominguez A. N. M., et al. 2025. "A Time‐Resolved Framework for the Recruitment of mRNP Processing and Assembly Factors to a Site of Transcription." Nucleic Acids Research 53, no. 15: gkaf798. 10.1093/nar/gkaf798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Wegener, M. , and Müller‐McNicoll M.. 2019. "View From an mRNP: The Roles of SR Proteins in Assembly, Maturation and Turnover." Advances in Experimental Medicine and Biology 1203: 83–112. 10.1007/978-3-030-31434-7_3. [DOI] [PubMed] [Google Scholar]
  212. Wigington, C. P. , Williams K. R., Meers M. P., Bassell G. J., and Corbett A. H.. 2014. "Poly(A) RNA‐Binding Proteins and Polyadenosine RNA: New Members and Novel Functions." WIREs RNA 5, no. 5: 601–622. 10.1002/wrna.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Williams, B. J. L. , Boyne J. R., Goodwin D. J., et al. 2005. "The Prototype γ‐2 Herpesvirus Nucleocytoplasmic Shuttling Protein, ORF 57, Transports Viral RNA Through the Cellular mRNA Export Pathway." Biochemical Journal 387, no. 2: 295–308. 10.1042/BJ20041223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Williams, T. D. , Michalak E. M., Carey K. T., et al. 2025. "mRNA Export Factors Store Nascent Transcripts Within Nuclear Speckles as an Adaptive Response to Transient Global Inhibition of Transcription." Molecular Cell 85, no. 1: 117–131.e7. 10.1016/j.molcel.202412008. [DOI] [PubMed] [Google Scholar]
  215. Woodward, L. A. , Mabin J. W., Gangras P., and Singh G.. 2017. "The Exon Junction Complex: A Lifelong Guardian of mRNA Fate." Wiley Interdisciplinary Reviews: RNA 8, no. 3: e1411. 10.1002/wrna.1411. [DOI] [PubMed] [Google Scholar]
  216. Xie, Y. , Clarke B. P., Xie D., et al. 2025. "Structures and mRNP Remodeling Mechanism of the TREX‐2 Complex." Structure 33, no. 2: 566–582.e6. 10.1016/j.str.2024年12月01日9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Xie, Y. , Clarke B. P., Kim Y. J., et al. 2021. "Cryo‐EM Structure of the Yeast TREX Complex and Coordination With the SR‐Like Protein Gbp2." eLife 10: e65699. 10.7554/eLife.65699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Xie, Y. , Gao S., Zhang K., et al. 2023. "Structural Basis for High‐Order Complex of SARNP and DDX39B to Facilitate mRNP Assembly." Cell Reports 42, no. 8: 112988. 10.1016/j.celrep.2023.112988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Yeh, F.‐L. , Chang S.‐L., Ahmed G. R., et al. 2021. "Activation of Prp28 ATPase by Phosphorylated Npl3 at a Critical Step of Spliceosome Remodeling." Nature Communications 12, no. 1: 3082. 10.1038/s41467-021-23459-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Zander, G. , Hackmann A., Bender L., et al. 2016. "mRNA Quality Control Is Bypassed for Immediate Export of Stress‐Responsive Transcripts." Nature 540, no. 7634: 593–596. 10.1038/nature20572. [DOI] [PubMed] [Google Scholar]
  221. Zander, G. , and Krebber H.. 2017. "Quick or Quality? How mRNA Escapes Nuclear Quality Control During Stress." RNA Biology 14, no. 12: 1642–1648. 10.1080/15476286.2017.1345835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Zenklusen, D. , Vinciguerra P., Strahm Y., and Stutz F.. 2001. "The Yeast hnRNP‐Like Proteins Yra1p and Yra2p Participate in mRNA Export Through Interaction With Mex67p." Molecular and Cellular Biology 21, no. 13: 4219–4232. 10.1128/MCB.21.13.4219-4232.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Zhang, K. , Cagatay T., Xie D., et al. 2024. "Cellular NS1‐BP Protein Interacts With the mRNA Export Receptor NXF1 to Mediate Nuclear Export of Influenza Virus M mRNAs." Journal of Biological Chemistry 300, no. 11: 107871. 10.1016/j.jbc.2024.107871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Zhang, K. , Miorin L., Makio T., et al. 2021. "Nsp1 Protein of SARS‐CoV‐2 Disrupts the mRNA Export Machinery to Inhibit Host Gene Expression." Science Advances 7, no. 6: eabe7386. 10.1126/sciadv.abe7386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Zhang, K. , Xie Y., Muñoz‐Moreno R., et al. 2019. "Structural Basis for Influenza Virus NS1 Protein Block of mRNA Nuclear Export." Nature Microbiology 4, no. 10: 1671–1679. 10.1038/s41564-019-0482-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Zhang, M. , and Green M. R.. 2001. "Identification and Characterization of yUAP/Sub2p, a Yeast Homolog of the Essential Human Pre‐mRNA Splicing Factor hUAP56." Genes & Development 15, no. 1: 30–35. 10.1101/gad.851701. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing are not applicable to this article as no new data were created or analyzed in this study.


Articles from Wiley Interdisciplinary Reviews. RNA are provided here courtesy of Wiley

ACTIONS

RESOURCES

AltStyle によって変換されたページ (->オリジナル) /